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iii. SUMMARY 
 
The work described in this thesis focuses on one member of the teneurin 
family: teneurin-1 (ten-1). The chicken ten-1 gene encodes a 300kDa protein. 
The intracellular domain of ten-1 harbours proline rich sequences, which serve 
as docking sites for SH3-domain containing proteins, followed by a 
transmembrane domain, an extracellular domain containing several EGF-like 
repeats involved in protein dimerization and 26 YD repeats. 
Regulated Intramembrane Proteolysis (RIP) initiates an event that 
involves the cleavage of type I and II transmembrane proteins, leading to the 
translocation of the cleaved intracellular domain into the nucleus to regulate 
transcription of target genes. Prominent proteins known to be activated through 
RIP are Notch, Amyloid Precursor Protein (APP), Sterol regulatory element-
binding protein (SREBP) and others. Recently, evidence of a cleavage 
mechanism of this type has also been obtained for the teneurin family of 
proteins. 
With the aim to identify binding partners of teneurin-1, yeast two-hybrid 
studies were performed. Both CAP/ponsin and MBD1 were found to interact 
with the intracellular domain of ten1 (IDten-1). In cell fractionation 
experiments, IDten-1 co-purified with CAP/ponsin and MBD1 in the nuclear 
matrix of U2OS cells. Moreover, when full-length teneurin-1 was expressed in 
cells in culture, the generation of IDten-1 could be detected, suggesting that 
this fragment is the result of an endogenous cleavage mechanism. 
Based on these observations, we concluded that IDten-1 either alone, or in a 
complex with CAP/ponsin and MBD1 could be involved in the regulation of 
transcription of yet-to-be identified target genes. To identify such target genes 
the gene expression profile of cells induced to express IDten-1 was compared 
to control cells not induced to express this domain. This analysis revealed a 
particular transcript, here defined as XM_039676, the expression of which was 
highly upregulated in the presence of IDten-1. This gene represents the first 
candidate for a RIP-induced target gene of ten-1. 
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I. Introduction  
Cell-cell and cell-extracellular matrix (ECM) interactions, in addition to 
ligand binding to a receptor, are of fundamental importance for cellular 
signalling. Surprisingly, despite the enormous complexity of our bodies, the 
repertoire of messages that pass between cells to coordinate the developmental 
processes is limited and relatively similar in kind. Among the molecules 
involved in the signalling network that orchestrates development, the teneurins 
emerged about eleven years ago as a novel family of proteins. Since then, 
elucidating teneurin function has been the objective of studies carried out in 
various laboratories. 
 
I. 1. The discovery of Teneurins 
The teneurins comprise a family of glycosylated type II transmembrane 
proteins that were originally discovered in Drosophila in a search intended to 
identify orthologues of the vertebrate tenascins. However, ten-a, the first 
teneurin member to be characterized (Baumgartner and Chiquet-Ehrismann, 
1993) and the second member, ten-m/odd oz (odz) (Baumgartner et al., 1994; 
Levine et al., 1994) turned out to be structurally and functionally distinct from 
the tenascins despite the high degree of conservation of their EGF-like repeats. 
Subsequently, the vertebrate orthologues of ten-a and ten-m were discovered. 
The nomenclature of the homologous proteins in different species is not 
standardized as different laboratories found and named members of this protein 
family independently. The actual term teneurin is mostly attributed to family 
members in chicken and man (Minet and Chiquet-Ehrismann, 2000; Minet et 
al., 1999). Oohashi et al. named the mouse proteins ten-m1, ten-m2, ten-m3 
and ten-m4, the latter being identical to mouse DOC4 (Oohashi et al., 1999). 
DOC4 was identified as a downstream target of the transcription factor CHOP 
(C/EBP homology protein) (Wang et al., 1998). In rat, a family member was 
termed neurestin. It is most similar to teneurin-2 and was cloned by Firestein 
and Otaki in 1999 (Otaki and Firestein, 1999a). Two zebrafish orthologues, 
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highly related to the mouse ten-m3 and ten-m4, were therefore termed 
accordingly (Mieda et al., 1999).  
 
Expression pattern of Teneurins 
The striking common feature among all these family members appears 
to be their highly conserved neuronal expression. In Drosophila for example, 
expression of ten-m coincides with the location of neurons involved in 
receiving, transmitting and processing visual inputs from the eye to the brain 
just as was found for teneurin-1 in the case of chicken (Minet et al., 1999). In 
rat, neurestin/teneurin-2 was found to be highly expressed in the brain and also 
in other tissues, but at much lower levels (Otaki and Firestein, 1999a). Its 
expression overlaps with the timing of synapse formation of olfactory sensory 
neurons and glomeruli immediately before and after birth. For that reason, 
neurestin was proposed to serve as a target recognition molecule involved in 
producing the olfactory perception by directing neurons to correct sites to form 
synapses and glomeruli (Otaki and Firestein, 1999b). The murine ten-m genes 
also show overlapping expression patterns during development and in the adult 
brain (Zhou et al., 2003). By in situ hybridization of parasagital brain sections, 
ten-m1 (teneurin-1) positive signals were first seen at E15.5 in forebrain, 
midbrain, hindbrain, spinal cord and trigeminal ganglion. In the adult brain, 
ten-m1 expression is present in the cortex, thalamus, hippocampus and in the 
granular layer subregion of the cerebellum. In chicken, Northern blot analyses 
of the brain, show highest expression levels between stages E11 and E17 and 
lower levels in the adult brain. By in situ hybridization, the most prominent site 
of expression is the developing visual system. At E7, teneurin-1 is present in 
the retina, telencephalon, optic tectum and diencephalon (Rubin et al., 1999) 
and at E17, the hybridization signal is still concentrated within the developing 
visual system and within interconnected brain areas suggesting a role in 
neuronal connectivity (Minet et al., 1999). Indeed, immunohistochemistry 
studies showed teneurin-1 and 2 expressions to be refined to neurons belonging 
to specific pathways (Rubin et al., 2002). Teneurin-1 expression was found to 
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belong to the tectofugal pathway, responsible for colour discrimination and 
brightness, whereas teneurin-2 was found to belong to the thalamofugal 
pathway, involved in detection of movements and also known to modulate the 
tectofugal pathway (figure 1). Because these expression patterns coincide with 
periods of target recognition and synaptogenesis, teneurin-1 and -2 have been 
suggested to be a regulator in the development of appropriate synapses in the 
avian visual system (Rubin et al., 2002). 
 
 
 
Taken from Rubin et al., Development, 2002. 
 
Figure 1. The primary visual pathways of the chick and patterns of teneurin 
expression. (A) There are two primary visual circuits in birds, the tectofugal pathway 
and the thalamofugal pathway. (B) Teneurin-1 is expressed by neurons in at least two 
of the three major parts of the tectofugal pathway (expression in the telencephalon has 
not been examined). Teneurin-2 is expressed by the neurons of the thalamofugal 
visual pathway. 
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Domain architecture and molecular properties of Teneurins 
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Figure 2 depicts the structural domains present in the teneurin-1 protein. 
The amino-terminal intracellular domain of teneurin-1 (IDten-1) contains a 
short sequence rich in prolines that can serve as docking sites for SH3-domain 
containing proteins (Mayer and Eck, 1995). Following the intracellular domain, 
the protein contains a hydrophobic stretch characteristic of a transmembrane 
domain and a long extracellular tail harbouring 8 consecutives highly 
conserved tenascin-type EGF-like repeats followed by 26 YD repeats.  
In addition to the immunohistochemistry, northern blotting and in situ 
hybridization studies described above, recombinant chicken teneurin-1 and 2 
proteins were also overexpressed to assay their molecular properties. In vitro, 
the YD repeats of teneurin-1 were reported to be important for carbohydrate 
binding and to promote neurite outgrowth when offered as a substratum, a 
property that can be inhibited by heparin (Minet et al., 1999). In a similar 
fashion, over expressed teneurin-2 in Nb2a neuroblastoma cells resulted in 
actin-containing teneurin-2-enriched filopodia and enlarged growth clones, 
which suggested an interaction of the cytoplasmic part of this protein with the 
cytoskeleton (Rubin et al., 2002; Rubin et al., 1999).  
Interestingly, a very intriguing feature of the teneurins is that they are 
the exclusive proteins in eukaryotes containing short repeats of about twenty 
amino acids containing the previously mentioned dipeptide tyrosine-aspartate 
sequence, the YD-repeats. Elsewhere, this domain is only found in the 
predicted protein of the rearrangement hot spot (rhs) elements in E. coli. Highly 
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related sequences are also found in the wall-associated protein A (WAPA) of 
B. subtilis and more distant related sequences are present in the toxin A of C. 
difficile (Minet et al., 1999). 
In other studies, recombinantly expressed mouse extracellular domains 
of ten-m1, ten-m2, ten-m3 and ten-m4 were able to form homo and hetero-
dimers in vitro via the EGF-dimerisation unit, indicating that teneurins are 
dimers (Feng et al., 2002; Oohashi et al., 1999). Dimerisation could also be 
observed in the case of chicken teneurin-1 (Nunes et al., 2005). Taking into 
account all the different homo- and heterodimers that could form (Feng et al., 
2002), in combination with the alternative splicing of teneurin transcripts 
(Tucker et al., 2001), a large variety of different molecular combinations are 
conceivable, which would significantly enhance the functional complexity of 
teneurin-ligand interactions. 
The EGF-like repeats of chicken teneurin-2, when overexpressed in cell 
culture, do not appear to play a role in the homophilic interaction that leads to 
the aggregation of cells in vitro. Instead, it was proposed that the aggregation 
depended on the part of the molecule distal to the EGF-like repeats (Rubin et 
al., 2002). Apart from the studies by (Feng et al., 2002; Oohashi et al., 1999) 
and (Rubin et al., 2002) knowledge on the functional properties of the EGF-like 
repeats for the teneurin family of proteins is scarce to date. In contrast, the 
highly related EGF-like repeats of tenascins have been investigated more 
thoroughly. It was found that tenascin-C elicits repulsive (or anti-adhesive) 
effects on oligodendrocyte precursor cell migration through two distinct 
mechanisms; (1) reduced substrate adhesion and (2) a direct inhibition of cell 
migration that is independent of adhesion. The repulsive effect on 
oligodendrocytes was then mapped to the EGF-like repeats and to the 
alternatively spliced FNIII repeats of the protein (Kiernan et al., 1996). 
Moreover, neurites and growth cones were shown to be strongly repelled from 
areas coated with fragments containing the EGF-like domains (among others) 
of tenascin-R. Importantly, the binding site of the neuronal receptor for 
tenascin-R, the immunoglobulin superfamily adhesion molecule F3/11, was 
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localized to the EGF-like domain (Xiao et al., 1996). The repulsive effect of the 
EGF-like repeats could be further confirmed in an ex-vivo assay of the central 
nervous system. Outgrowth of embryonic and adult retinal ganglion-cell axons 
from mouse retinal explants was significantly reduced on homogeneous 
substrates containing tenascin-R or a bacterially expressed tenascin-R fragment 
comprising the EGF-like repeats (Becker et al., 2000). Later on, it was 
proposed that selected EGF-like repeats of tenascin-C elicit mitogenesis and 
EGFR autophosphorylation in an EGFR-dependent manner (the repeats being a 
novel EGFR-ligand class) (Swindle et al., 2001). In addition, the EGF-like 
repeats of tenascin-C were shown to be involved in EGF-receptor signalling of 
myofibroblasts that are present at the invasion front in colon cancer (De Wever 
et al., 2004). These cells are able to secrete two converging signals, namely the 
scatter factor/hepatocyte growth factor and tenascin-C. For proper pro-invasive 
and permissive signalling of SF/HGF, it is believed that the EGF-like repeats of 
tenascin-C contribute to the responses necessary for the transformation of a 
nonmigratory morphotype of the myofibroblasts to a migratory one, namely by 
inducing changes in RhoA and Rac expression.   
Elsewhere than in tenascins, the equivalent domain mediates diverse 
functions. Over 100 cell surface and secreted molecules have been found to 
contain EGF repeats. In Notch, the EGF-like repeats are O-fucosylated to form 
the substrate of Fringe β1,3-N-acetylglucosaminyltransferases and are 
necessary for proper Notch signalling at developmental boundaries (Moloney 
et al., 2000) (Bruckner et al., 2000). Moreover, the hint that O-fucosylation is 
essential for Notch signalling in mammals came from studies demonstrating 
that mouse embryos lacking O-fucosyltransferase 1 die at midgestation with 
several defects (Shi and Stanley, 2003). Furthermore, the EGF-like repeats are 
also necessary for Notch interaction with delta and serrate during the 
development and patterning of the wing disc in Drosophila (Lawrence et al., 
2000). 
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I. 2. Signal transduction by membrane proteins  
Cells have learned to respond to various stimuli from their environment 
in a rapid and efficient manner by inducing changes in their gene expression 
program. This trans-membrane signalling is achieved by receptors or sensors, 
which are triggered by the stimuli. The signal is then relayed within a specific 
signalling cascade comprised of several effector proteins by mechanisms such 
as post-translational modifications (e.g. phosphorylation) or non-covalent 
interactions.  
 Despite the high complexity and diversity of multicellular organisms 
only a limited number of conserved signalling pathways are used repetitively in 
the different tissues and organisms throughout evolution to orchestrate the 
developmental processes. The Wnt/wingless-, BMP/TGF-beta-, sonic 
hedgehog-, receptor tyrosine kinase-, nuclear receptor-, JAK/STAT and Notch-
pathway are some of the most prominent examples. The signal transducers and 
activators of transcription (STAT) are among the best-studied latent 
cytoplasmic signal-dependent transcription factors. The STAT transcription 
factors are activated by phosphorylation on conserved tyrosine and serine 
residues in their C-terminal domains following cytokine signalling or by 
various stress-induced stimuli. Janus kinases (JAKs) and mitogen-activated 
protein kinase (MAPK) are among the kinases that phosphorylate the STATs 
and allow them to dimerise and to translocate to the nucleus where they 
regulate gene expression (Ihle, 2001); reviewed in (Leonard and O'Shea, 1998). 
The unexpected finding that mechanisms of regulated proteolysis can be 
involved in triggering activation of transcription factors by processing an 
inactive membrane-precursor form to generate its active soluble form has 
opened up an entirely new field of research on transmembrane proteins.  
Regulated intramembrane proteolysis (RIP) (Brown et al., 2000; 
Kanehara and Akiyama, 2003) and regulated ubiquitin/proteasome-dependent 
processing (RUP) (Hoppe et al., 2001) are examples of the cleavage events 
described above. They are novel mechanisms added to the list of cellular 
strategies to mobilize membrane-anchored proteins for signalling purposes. In 
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the case of RIP, the signalling pathway starts by a mechanism where substrates 
are hydrolysed within the hydrophobic environment of the membrane by 
specific membrane-bound proteases. In the case of RUP, the proteolysis 
machinery involved is the proteasome. For teneurin-2, RUP was considered 
unlikely to be responsible for its proteolytic cleavage since proteasome 
inhibitors actually enhanced the amount of the cleaved intracellular domain 
(Bagutti et al., 2003). 
Studies on RIP have started about seven years ago, with the discovery 
that cholesterol not only had a role in modulating the fluidity of plasma 
membranes, but also in association with sphingomyelin was responsible for the 
formation of plasma membrane rafts or caveolae. Rafts are storage sites for 
signalling molecules and cells need to maintain a constant level of cholesterol, 
in order to control homeostasis, integrity and function (Anderson, 1998; 
Simons and Ikonen, 1997). To achieve this task, RIP is necessary for the 
activation of SREBPs (Sterol regulatory element-binding proteins), which are 
membrane-bound transcription factors responsible for cholesterol homeostasis 
in plasma membranes, cells and blood of animals. SREBPs enhance the 
synthesis and uptake of cholesterol and fatty acids. When cells are replete with 
sterols, SREBPs remain bound to the membranes of the endoplasmic reticulum 
(ER) and are therefore inactive. Serbs are bound to the membrane by a 
multipass membrane protein called SCAP (SREBP cleavage-activating protein) 
that itself is bound to a small membrane protein called Insig. When cells are 
depleted of sterols, Insig dissociates from SCAP. This event allows SCAP to 
now guide SREBP to move from the ER to the Golgi complex. There, two 
proteases release the active portions of the SREBPs, which then enter the 
nucleus and activate transcription of target genes (Goldstein et al., 2002). 
Another extensively studied endoplasmic reticulum transmembrane 
protein is the activating transcription factor 6 (ATF6), which is proteolytically 
activated in response to ER stress. Normally, the steps involved in the 
activation of membrane-anchored transcription factors are tightly regulated. 
For example, the transport of ATF6 from the ER to the Golgi apparatus and 
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that from the Golgi to the nucleus are distinct steps that can be distinguished by 
treatment with the serine protease-inhibitor AEBSF (Okada et al., 2003).  
Since teneurins are transmembrane proteins (Oohashi et al., 1999; Rubin 
et al., 1999) and Drosophila ten-m was intriguingly found to be the first 
member of a pair-rule gene not encoding a classical transcription factor 
(Baumgartner et al., 1994), the hypothesis emerged that a regulated cleavage 
event taking place extracellularly may be involved in activation of the protein. 
As a consequence of that, liberation of an intracellular domain would 
ultimately signal to the transcription machinery. That could in turn help to 
explain the discrepancy observed in Drosophila between the mRNA and the 
protein expression pattern. In Drosophila, the ten-m/odz gene is expressed in 
odd-numbered segments of the developing embryo but the protein is found to 
be secreted (Baumgartner et al., 1994), most likely as a result of a cleavage 
event.  So far, evidence for an extracellular cleavage at a furin site has been 
obtained for teneurin-2 (Rubin et al., 1999) but the physiological protease 
responsible for the liberation of the intracellular domain remains to be 
identified. The intracellular domain of teneurin-2 was shown to have a nuclear 
function in repressing zic-mediated transcription (Bagutti et al., 2003). Zic 
genes are the vertebrate homologues of the Drosophila zinc-finger transcription 
factor opa that was shown to cooperate with ten-m in the same signalling 
cascade (Baumgartner et al., 1994).  
 
I. 3. Intramembrane-cleaving proteases (I-CLiPs) 
I-CLiPs are multispanning, integral membrane proteins that have 
classical protease motifs within their putative transmembrane domains (Golde 
and Eckman, 2003; Weihofen and Martoglio, 2003). I-CLiPs cleave their 
substrates in the plane of the membrane, although the precise mechanism of 
peptide-bond hydrolysis is not fully understood. They can be grouped in three 
main families that differ in their mechanistic class and in the topology of their 
substrates (see tables 1 and 2) (Kopan and Ilagan, 2004). I-CLiPs regulate 
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diverse biological processes in a wide range of organisms from archaea to 
humans (Brown et al., 2000; Urban and Freeman, 2002). 
Among the intramembrane-cleaving proteases, the discovery of 
presenilin (PS) in 1995 through positional cloning was particularly important to 
illuminate a key mechanistic feature of Notch signalling that remained elusive 
and controversial for many years (Rogaev et al., 1995). Of special interest, 
presenilin has been later shown to be involved in the production of amyloid 
beta peptides (Aβ) from amyloid precursor protein (APP) in Alzheimer's 
disease (Haass and De Strooper, 1999). Presenilins are multifunctional proteins 
and function as the catalytic subunit of the γ-secretase complex, an 
intramembrane aspartyl protease. In order to acquire a functional γ-secretase 
active site, presenilin goes through a conformational change induced by 
endoproteolysis. Furthermore, it has to be in complex with other co-factors 
such as nicastrin, anterior pharynx defective-1 (APH-1) and presenilin 
enhancer-2 (PEN-2) (Xia and Wolfe, 2003). In yeast, functional reconstitution 
of γ-secretase activity requires all four components (Edbauer et al., 2003; 
Kimberly et al., 2003; Luo et al., 2003; Takasugi et al., 2003). 
Cervantes et al. and others have previously shown that presenilin 
homodimerises and suggested that a presenilin dimer is at the catalytic core of 
γ-secretase. Later on, they were able to demonstrate that the transmembrane 
domains of these proteins contribute to the formation of the dimer. Both 
presenilinase and γ-secretase activities were abolished by an in-frame 
substitution of the hydrophilic loop 1, which is a region that modulates the 
interactions within the N-terminal fragment/N-terminal fragment dimer. In 
addition, they also provided evidence that specific diaspartyl groups within the 
presenilin catalytic core of γ-secretase mediate the cleavage of different 
substrates (Cervantes et al., 2001; Cervantes et al., 2004).  
In addition to Notch and APP, an increasing number of proteins were 
subsequently shown to be cleaved by γ-secretases in the last years. Intriguingly, 
these γ-secretase substrates turned out to be a set of diverse proteins, such as 
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e.g. ErbB4, E-cadherin, N-cadherin, CD44, Nectin-1α, syndecan-3, Delta, 
Jagged and ApoER2, implicating γ-secretase in normal cellular processing 
events (reviewed in (Medina and Dotti, 2003)).  
Interestingly, the amino acids within the transmembrane domains of 
these substrate molecules share little homology suggesting that γ-secretase 
might not require a specific consensus sequence for activity (Struhl and 
Adachi, 2000) supporting the concept that co-factors are necessary for protease 
activity.  
γ-secretase cleaves APP and other type I transmembrane proteins in the 
process of regulated intramembrane proteolysis, in which an obligatory first 
cleavage sheds most of the ectodomain and allows the substrate to undergo 
subsequent intramembranous cleavage. 
Moreover, the so-called "spatial paradox" which refers to the apparent 
discrepancy between PS localisation (residing mainly in the endoplasmic 
reticulum, trans-Golgi network and intermediate compartments) and γ-secretase 
activity seems to be solved. Chyung and colleagues were the first to recently 
demonstrate that γ-secretase exists on the plasma membrane as an intact 
complex that accepts substrates and effects intramembrane cleavage (Chyung 
et al., 2004). 
Related to the presenilin family are the signal-peptide peptidases (SPP) 
that remove membrane-associated signal peptides (Weihofen et al., 2002). SPP 
cuts type II transmembrane proteins, illustrating that presenilin-like proteases 
play a key role in intramembrane proteolysis of single-pass membrane proteins 
oriented in either direction (Xia and Wolfe, 2003). However, in contrast to 
presenilin that is not active unless part of a larger complex, SPP does not 
appear to require protein co-factors. In addition, because of its requirement for 
hepatitis C virus maturation and a possible immune modulatory role, SPP is 
also considered a potential therapeutic target (Martoglio and Golde, 2003). 
In conclusion, the intramembrane cleaving proteases participating in 
RIP initiate similar cellular responses. By means of regulated proteolysis, 
membrane bound signalling proteins and transcription factors that are kept in a 
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dormant state, have the potential to be activated rapidly by certain stimuli to 
control gene expression. Nonetheless, one has to keep in mind that neither RIP 
nor RUP processes are restricted to the activation of transcription factors or to 
the regulation of nuclear import. For example, in the case of N-cadherin, the 
released intracellular domain associates with the transcriptional activator 
CREB binding protein (CBP) and promotes its export to the cytosol and 
degradation by the proteasome (Marambaud et al., 2003). Furthermore, the 
release of the EGF orthologue Spitz by Rhomboid proteolysis does not 
generate a transcription factor, but a secreted growth factor instead (Lee et al., 
2001). In fact, all I-CLiPs discovered so far have important biological activities 
and are tightly regulated, but the means of control vary. They are all involved 
in cell signalling, but as mentioned above, some release specialized 
transcription factors (S2P), whereas others generate transcriptional modulators 
and/or contribute to degradation of their substrates (γ-secretase and SPP). Other 
I-CLiPs generate fragments that can act as immune system surveillance 
molecules (SPP) or secreted growth factors (Rhomboid) (Wolfe and Kopan, 
2004). 
Finally, it is of interest to note that several presenilin and γ-secretase 
substrates, such as e.g. DCC, ErbB4, Delta and p75NTR are known to 
influence neuronal structure and function, and are important for nervous system 
development (Koo and Kopan, 2004).  
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Table 1. Intramembrane-cleaving proteases  
      iCLiP family                 Substrate            Substrate                          Substrate 
(mechanistic class)             topology*                                                       function  
 
Aspartyl proteases 
Presenilin (γ-secretase)         type I                  (see table 2)                         (see table 2) 
 
Signal-peptide peptidase      type II                 MHC-class-I                Immune surveillance 
(PSH3) 
 
Metalloproteases                                                                                                              
Site-2-protease                     type II                  SREBP                             Sterol regulation  
                                                                          ATF6                         Unfolded protein response 
 
Eep                                       type II                 cAD1 pheromone       Pheromone release during 
                                                                                                            conjugation  in  E.faecalis 
Serine proteases  
Rhomboid                            type I                  Spitz, Keren and              Ligands for EGFR 
                                                                        Gurken                          signalling in Drosophila  
 
Aar A                                   type I                  Unknown               Quorum sensing in P.stuartii  
         
 
* type-I topology - amino terminus is lumenal/extracellular, carboxy terminus is cytoplasmic; 
type-II topology - amino terminus is cytoplasmic, carboxy terminus is lumenal/extracellular. 
ATF6, activating transcription factor-6; EGFR, epidermal growth factor receptor; MHC, 
major histocompatibility complex; PSH, presenilin homologue; SREBP, sterol regulatory 
element binding protein; E. faecalis, Enterococcus faecalis; P. stuartii, Providencia stuartii. 
This table has been modified. For reference information see Kopan and Ilagan, Nature Reviews, 2004. 
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Table 2. γ-Secretase substrates and their proposed biological functions 
Substrate       Known role                Mechanism regulating              Function of released 
                                                            ectodomain shedding/               intracellular domain 
                                                             γ-secretase cleavage                               (ICD) 
 
 
APP             Pathological role in          Constitutive? F-spondin                  Forms transcription 
                    Alzheimer's disease                ligand binding?                          complex with FE65 
                    physiological role in                                                                          and TIP60?  
                    transport/adhesion?     
 
 
N-cadherin     Cell adhesion              Membrane depolarization;                   Promotes CBP 
                                                            NMDA-receptor activation                    degradation                                          
 
 
DCC             Netrin-1 receptor                Constitutive?                     ICD-Gal4 fusion construct 
                                                                                                       activates Gal-4 reporter-gene 
                                                                                                         
                                                                                                               
Notch 1-4     Signalling receptor               Ligand binding               Transcriptional  regulation 
 
CBP, CREB (cAMP-responsive-element binding protein)-binding protein; ICD, intracellular 
domain; DCC, deleted in colorectal cancer; NMDA, N-methyl-D-actetate;   
This table has been modified. For reference information see Kopan and Ilagan, Nature Reviews, 2004. 
 
 
I. 4. Regulated intramembrane proteolysis in Alzheimer's disease and in 
Notch signalling 
 
Alzheimer's Disease (AD), the most common age-associated 
neurodegenerative disorder is characterized by a loss of neurons and synaptic 
dysfunction in the cortex, hipoccampus and many other structures involved in 
judgment, memory and emotions. This is assumed to be an important cause for 
the cognitive impairment seen in patients. (Koo and Kopan, 2004; Selkoe, 
2002; Terry et al., 1991). It is believed that abnormal processing of the amyloid 
precursor protein (APP) contributes to pathogenesis as an initiating factor due 
to the deposition of the amyloid peptide (residues 38-43 of the processed 
amyloid beta (Aβ) protein) in the form of plaques in the brain (Hardy and 
Selkoe, 2002; Katzman, 1986). A major accompaniment of this event is the 
activation of kinases in the neuronal cytoplasm, leading to 
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hyperphosphorylation of the microtubule-associated protein tau, and its 
polymerization into insoluble neurofibrillary tangles (figure 3) (Selkoe, 2004; 
Walsh and Selkoe, 2004). Aβ is generated normally throughout life by virtually 
all-mammalian cells. APP is a ubiquitous type I membrane glycoprotein that 
occurs as a heterogeneous group of polypeptides arising from alternative 
splicing, N- and O-linked glycosylation, phosphorylation, sulphation, 
glyosoaminoglycan addition and complex proteolysis. Aβ is released from APP 
through sequential cleavages by β-secretase (also called BACE-1), a 
membrane-spanning aspartyl protease with its active site in the lumen and γ-
secretase. In addition, APP undergoes both constitutive and regulated secretory 
cleavages by certain metalloproteases referred to as α-secretases, principally 
believed to be ADAM 10 and ADAM 17. The α-secretase cleavage occurs 
primarily between residues 16 and 17 of the Aβ region of APP, and any 
precursors cleaved at this position cannot yield toxic Aβ peptides. Instead, 
processing by α-secretase followed by γ-secretase generates a smaller 
hydrophobic fragment referred to as p3, whose normal function and role in 
Alzheimer's disease (if any) is unclear. 
α-secretase processing releases the large APP ectodomain (APPs-α) 
from the cell. Several biological activities have been ascribed to this secreted 
derivative in vitro, including as a trophic or neuroprotective factor, a serine 
protease inhibitor and a cell-substrate adhesion molecule. Sequential 
processing by α-secretase and γ-secretase also releases the APP intracellular 
domain (AICD), a portion of which can bind to the cytoplasmic adaptor protein 
Fe65, and apparently help mediate aspects of nuclear signalling. However, 
there has been no consensus so far as to which transcripts may be regulated by 
complexes shown to contain AICD, Fe65 and the histone acetylase Tip60 
(Selkoe, 2004). 
Although the inherited form of Alzheimer disease accounts only for a 
minor fraction of reported cases, genetic studies led to the important finding 
that early-onset, dominant forms of familial AD (FAD) are caused by 
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mutations in APP, presenilin 1 (PS1) and presenilin 2 (PS2) proteins (Goate et 
al., 1991; Hardy and Allsop, 1991; Hendriks et al., 1992; Mullan et al., 1992) 
consistently associated with selective increases in Aβ42 peptides or total Aβ 
levels (Murayama et al., 1999).  
However, the observations that presenilin modulates proteolysis and 
turnover of several signalling molecules have led to speculations that other 
pathways that are important in development may also contribute to 
neurodegeneration. Moreover, since the majority of AD cases do not carry 
presenilin mutations, it remains to be clarified whether other mechanisms 
contribute to the accumulation of Aβ. One such option would be for example 
the age-dependent reduction in Aβ clearance or degradation originating from 
accumulated insults throughout life. Mechanisms that are not related to Aβ, but 
primary related to presenilin activity instead, have been reviewed in (Koo and 
Kopan, 2004) and are considered as contributors to sporadic cases of AD. 
Interestingly, a crucial determinant in Aβ generation is the targeting of 
the protein to the correct subcellular site. For example, amyloidogenic 
processing of the β-amyloid precursor protein depends on lipid rafts. APP 
within rafts appears to be cleaved by β-secretase whereas APP outside rafts 
undergoes cleavage by α-secretase (Ehehalt et al., 2003). 
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Adapted from Selkoe, Nature Cell Biology, 2004 and Walsh and Selkoe, Neuron, 
2004.  
 
Figure 3. Model of key events underlying the pathogenesis of Alzheimer's disease. 
APP on the plasma membrane and in intracellular vesicles is cleaved by BACE and 
the presenilin-γ-secretase complex (PS-γ) to liberate the Aβ region. A portion of Aβ 
can oligomerize and is released into the interstitial fluid of the brain. These soluble 
oligomers may diffuse into synaptic clefts and interfere with synaptic function. Aβ 
can further polymerize into insoluble amyloid fibrils that aggregate into spherical 
plaques, resulting in dysfunction of adjacent axons and dendrites. The activation of 
kinases in the neuronal cytoplasm leads to the hyperphosphorylation of the 
microtubule-associated protein tau and its polymerization into insoluble filaments 
defined as neurofibrillary tangles. The different Aβ assembly forms may mediate 
diverse effects, such as decreased synaptic efficacy, distortion of axonal pathways, 
shrinkage of dendritic arbors, activation of microglia, free radical release and 
inflammatory changes that may contribute to neurotoxicity.  
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Notch signalling has been implicated in a wide variety of processes 
from cell-fate decisions, tissue patterning and morphogenesis to human 
diseases and cancer. In most cases, Notch signalling acts as a "gatekeeper 
against differentiation" because it blocks differentiation towards a primary 
differentiation fate and instead directs the cell to a second, alternative 
differentiation program or forces the cell to remain in an undifferentiated state. 
In addition to its classical role in lateral inhibition, recent findings demonstrate 
that Notch signalling is instructive, by actively promoting a particular cell fate. 
For instance in the nervous system, Notch promotes differentiation of glial cell 
types e.g. astrocytes, Schwann cells, Muller glial cells and radial glial cells 
(Hansson et al., 2004). Notch signalling has also been shown to be important in 
post-development processes, for example, in synaptic plasticity of the 
hippocampus (Wang et al., 2004) and in contributing to long-term memory 
formation in the adult brain of Drosophila (Ge et al., 2004). 
Activation of Notch is accomplished by multi-step cleavage events. The 
receptor is synthesized as a 300 kDa precursor form in the endoplasmic 
reticulum and transported via the secretory pathway to the trans-Golgi 
compartment where it is cleaved by furin convertases at cleavage site 1 (S1). 
This cleavage leads to the formation of a functional heterodimeric receptor at 
the cell membrane (Blaumueller et al., 1997; Logeat et al., 1998). S1 cleavage 
is necessary for cell-surface expression and is not directly involved in the 
ligand-induced release of the active intracellular domain.  
Ligand-receptor interaction occurs between cells in physical contact. 
Upon binding ligands of the delta/jagged/serrate/LAG-2 family, a TNF-α 
converting enzyme (TACE) mediates cleavage at site 2 (S2), at a consensus site 
12 amino acids juxtaposed to the plasma membrane and removes the 
extracellular portion of the Notch heterodimer (Brou et al., 2000; Mumm et al., 
2000). The S2 cleavage event probably serves as a trigger for an additional 
third cleavage. This latter cleavage is presenilin-mediated and efficiently 
removes the remaining membrane-anchored intracellular signalling domain at 
site 3 (S3).   
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A special family of transcriptional effector proteins, the CSL (human C 
promoter binding factor 1-CBF1/ fly Suppressor of hairless/ worm Lag-1) 
factors (Bray and Furriols, 2001) and the Mastermind (Mam)/Lag-3 co-
activator (Petcherski and Kimble, 2000a; Petcherski and Kimble, 2000b) 
provide the link between Notch activation and gene regulation. Notch 
intracellular domain (NICD) translocates into the nucleus and assembles into a 
ternary complex with CSL, which binds specific regulatory DNA sequences 
and activates the expression of CSL/Notch target genes. For reviews see 
(Schroeter et al., 1998; Schweisguth, 2004; Struhl and Adachi, 1998). An 
illustration of these processes can be seen in figure 4. 
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Adapted from Ebinu and Yankner, Neuron, 2002. 
 
Figure 4: Signalling by Regulated Intramembrane Proteolysis (RIP). 
Several proteins known to signal by RIP are illustrated. Upon cholesterol depletion, 
SREBP is transported to the Golgi, where it undergoes intraluminal cleavage (site1) 
followed by transmembrane cleavage (site 2). Consequently, an N-terminal fragment 
is released that translocates to the nucleus and activates transcription of lipid 
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biosynthetic genes. Binding of the ligand Delta to its receptor Notch triggers 
intramembrane proteolytic cleavage by γ-secretase. This results in the release of the 
Notch intracellular domain (NICD), which then translocates to the nucleus where it 
associates with the CSL family of DNA binding proteins and transactivates gene 
expression. Constitutive γ-secretase cleavage of APP leads to the generation of the 
CTF-γ fragment. In overexpression systems, this fragment associates with the adaptor 
protein Fe65 in the nucleus to form an active transcriptional complex with the histone 
acetyltransferase Tip60. Activation of the receptor tyrosine kinase (ErbB-4) by its 
ligand neuregulin can trigger the proteolytic release of the ErbB-4 C-terminal 
fragment (ErbB-4/CTF). 
 
 
 
I. 5. The nucleus  
Because my work will focus to a large extent on elucidating the 
functions of the intracellular domain of teneurin-1 in gene regulation, the 
following section is dedicated to the nucleus, a highly organized cellular 
compartment. 
In a didactic manner, the eukaryotic genome can be comprehended as a 
system running at different hierarchical levels, in which regulatory mechanisms 
are integrated at three levels (van Driel et al., 2003). The first one is the 
sequence, where all the yet-to-be deciphered information is stored in the form 
of linear organized transcription units, coding regions and regulatory 
sequences. At this level, developmentally co-regulated genes are sometimes 
organized in clusters, constituting individual functional units per se. Above the 
linear level, stands the second level, chromatin, a very complex platform where 
yet-to-be discovered mechanisms determine gene expression profiles, dictating 
entire chromosomal regions whether to be in a functional state or not. To 
modify gene expression at the chromatin level, factors contributing to histone 
modification, DNA methylation and a variety of repressive and activating 
mechanisms also come into play. Besides the rough distinction between 
euchromatin and heterochromatin, chromatin can exist in many more different 
structural and functional states, which exhibit different core histone 
compositions and post-translational modification of histones (the "histone 
code"). This regulatory level is combined with control mechanisms that switch 
individual genes in a cluster on and off, depending on the properties of the 
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promoter. Finally, the third level is the nuclear level, which includes the three 
dimensional spatial organization of the genome within the nucleus.  
The architecture of the nucleus is closely related to genome function and 
the position of a gene inside the nucleus is important: some areas are repressive 
and some promote transcription. In order to impose these levels of control, the 
nucleus is compartmentalized into different foci and domains. 
In recent years there seems to be an increasing interest on the roles of 
different nuclear compartments and subnuclear domains in the regulation of 
gene expression, signalling and cellular functions (Zimber et al., 2004). For the 
cytoplasm this has been long known. It is structured in a manner that allows 
different organelles to perform their highly specialized functions. In analogy, 
complex substructures are also found in the nucleus and specific functions are 
thought to occur in different domains with typical morphology. In some cases, 
these domains have been shown to be dynamic structures with rapid exchange 
of proteins between them and the nucleoplasm (Misteli, 2001). As a 
consequence of these nuclear dynamics, some special foci can become 
transiently nuclear matrix associated and influence the transcriptional status of 
genes by facilitating their interaction with repressors or activating proteins, 
represented in figure 5. For example, nuclear bodies (NBs) are a group of 
intranuclear (nucleoplasmic) structures, situated within the nuclear matrix (see 
I.6) that is mainly distinguishable by morphological and antigenic criteria. NBs 
include several species containing granular and fibrillar materials and can be 
arranged as "coiled bodies", vesicles, spheres, or doughnut-like structures. The 
nuclear matrix provides a structural substratum for NBs. A summary of NB 
appearance and composition is seen in table 3 adapted from (Zimber et al., 
2004). The importance of these subnuclear structures is exemplified by 
perturbations in their composition and organization that accompany the onset 
and progression of disease (Cook, 1999; DeFranco, 2002; Misteli, 2000; 
Penman, 1995; Stein et al., 2000; Stenoien et al., 2000).      
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Adapted from Stein, Journal of Cell Science, 2000 
 
Figure 5: Panel A: Transcription of protein-encoding genes by RNA polymerase II 
occurs at a large number of foci (red ovals), and rRNA transcription by RNA 
polymerase I is restricted to one or more nucleoli (dark grey ovals). Both types of 
transcriptional foci are distinct from sites involved in DNA replication (Wei et al., 
1998). Gene regulatory factors (e.g. AML, hormone receptors), chromatin-
remodelling proteins (e.g. SWI/SNF), and processing factors (e.g. SC35) are 
organized into discrete subnuclear foci, a subset of which is associated with RNA 
polymerase II, depending on biological conditions. Chromatin-remodelling proteins 
mediate the transition between transcriptionally inactive "closed" chromatin 
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(heterochromatin) and active "open" chromatin (euchromatin) through a series of 
enzyme-mediated regulatory steps. The nuclear pore (open ovals) function in the 
nuclear import of regulatory proteins containing nuclear localization signals (NLSs). 
Intranuclear trafficking of proteins through subnuclear foci associated with the 
nuclear matrix involves specific nuclear-matrix targeting signals (NMTSs). PML 
domains (purple ovals) are specialized subnuclear domains that are rearranged in 
promyelocytic leukemias. SC35 domains (yellow ovals) contain RNA-splicing factors 
that generate mature mRNA transcripts. 
Panel B: A model for dynamic modifications in the interactions of gene regulatory 
factors at subnuclear foci associated with the nuclear matrix. Subnuclear 
compartments containing inactive "closed" chromatin (grey ovals) are converted to 
"open" chromatin by SWI/SNF remodelling proteins. This opening of chromatin 
promotes accessibility of gene regulatory factors (e.g. transcription factors [TFs], dark 
blue; steroid hormone receptors [SHRs], golden brown) that recruit RNA polymerase 
II. Histone acetyltransferases and deacetylases (HDACs) mediate the reversible (de) 
acetylation of histones to influence nucleosomal organization. Nascent transcripts are 
processed into mature mRNAs at SC35 transcript processing foci (yellow oval). 
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Table 3. Major nuclear bodies, their number, diameter, molecular composition and known or proposed functions in interphase eukaryotic cells 
                    Number per         Diameter                 Major constituents (components)                                                 Established or proposed functions      
                    cell (range)            (µm)       
 
Splicing          25-30                0.8-1.8                        pre-mRNA splicing factors                                       Storage sites of pre-mRNA splicing factors; correspond to 
specklesa                                 (in IGCs)                                                                                                  interchromatin granule clusters (IGCs) and to perichromatin  
                                         fibrils (PFs); involved in the storage of SR proteins and the 
                                                                                                                                                                        assembly and/or the modification of pre-mRNA 
                                                                                                                                                           
Cajal bodies     0-10                0.1-2.0                    p80 coilin; fibrillarin; U1, U2, U4/U6,                        snRNP biogenesis; trafficking of snoRNPs and snRNPs 
(and Gems)a,b,c                                                         and U5 snRNPs; U7 snRNP for histone                             to nucleoli or to splicing speckles, respectively,     
                                                                               3'-end processing; U3 and U8 snoRNPs                                               snRNA modification 
                                                                              for pre-rRNA processing; histone U1, U2 
                                                                                      U3, U4 and U12 genes 
         
Nucleolusa,b     1-5                   0.5-5.0                    p80 coilin, fibrillarin Nopp 140; ARF,                                rDNA transcription; rRNA biogenesis, metabolism; 
                                                                              MDM2, p53; components of telomerase                                               cell cycle regulation; cell lifespan  
                                                                                                                                                                        
Perinucleolar                           0.25-1.0                 PTB/hnRNPI, and several other RNA-                                     RNA processing; accumulation of newly 
compartmentb,c                                                       bindind proteins (KRSP); small RNAs                                     synthesized RNA (for further processing 
                                                                              transcribed by RNA polymerase III                                                           or retention?) 
 
PML-NBsa,b,c   10-30                0.3-1.0               Sp-100; Daxx; CBP; HAUSP; p53; Rb;                                 transcriptional regulation (e.g.Pax3); replication and 
                                                                       ...(sumoylation is needed) human MHC locus                          transcription of nuclear-replicating DNA viruses, genes 
                                                                       (chromosome 6) is preferentially associated with                     and proteins (herpes viruses, adenoviruses and papova 
                                                                      PML-NBs note: chromatin and RNA are not found                                               virus) 
                                                                                              in PML-NBs 
Cleavage  
bodiesa,b,d      1-4foci              0.3-1.0              contain several factors that are necessary for cleavage                some cleavage bodies are adjacent to or overlap 
                                                                   and polyadenylation steps of mRNA processing                 CBs; there may be distinct subclasses of these bodies  
 
PML-NBs and cleavage bodies are often found juxtaposed to Cajal bodies/Gems. The significance of these associations is not known. aThe number, size and integrity of these NBs depend on cellular activity (i.e., 
transcriptional), or cell cycle. bNBs that are more abundant in transformed and cancer cells (as compared to normal cells). cThese NBs were shown to be dynamic structures and mobile within the nuclear space (as 
determined by fluorescence-imaging techniques in living cells). dNPD=nuclear compartments. 
This table has been modified. For reference information see Zimber et al., Cellular Signalling, 2004. 
 
Samantha Michele Nunes Radimerski                                                                   35
Introduction 
I. 6. The nuclear matrix 
The nuclear matrix can be defined as a “compartment” which provides 
the surface for the attachment of multienzyme complexes involved in RNA and 
DNA metabolism (Baskin, 1995; Jackson et al., 1981). The nuclear matrix can 
be considered as the backbone/skeleton of the nucleus. 
Berezney and Coffey first coined the actual term "nuclear matrix" to 
define the residual nuclear structures observed after removal of DNA and 
histones by high-salt extraction and mild nuclease treatment in pioneering 
experiments in the early 1960s (Georgiev and Chentsov, 1960; Razin). 
Surprisingly, this harsh treatment still resulted in the retention of shape and 
morphological features of the cell nuclei (Berezney et al., 1979; Berezney and 
Coffey, 1974; Berezney and Coffey, 1975). Therefore, Berezney and Coffey's 
definition of the nuclear matrix was "the residual proteinaceous structure that 
remains after the nuclei are depleted of the nuclear membranes, histones, 
soluble nuclear proteins and nucleic acids" (figure 6).  
 
Residual nucleolus
Fibrogranular internal
nuclear matrix
Nuclear lamina Residual nuclear pore 
 
Adapted from Razin (Razin). 
Figure 6: Scheme of the nuclear matrix as observed by Berezney and Coffey. 
Treatment of isolated nuclei with nucleases, sequential extractions with low salt 
(0.2mM MgCl2, 10mM Tris-HCl) and high salt (2M NaCl) solutions, extraction with 
1% triton X100 followed by a second treatment with nucleases still retained a residual 
nuclear shape defined as nuclear matrix. 
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The attention of other scientists to this field of research was caught only 
10 years after the initial discovery of the nuclear matrix. The interest was 
driven by the first demonstration of an association between active replication 
complexes and the nuclear matrix (Berezney and Coffey, 1975). Over the 
years, this concept has been supported by experimental evidence. Recent 
studies demonstrate that DNA replication initiates at domains overlapping with 
nuclear matrix attachment regions in the xenopus and mouse c-myc promoter 
(Girard-Reydet et al., 2004). The functional relationship between nuclear 
matrix and replication will be discussed later on. 
Matrix preparations have been shown to contain 85-95% protein and 5-
15% nucleic acids. (Nakayasu and Berezney, 1991) have identified the major 
rat liver nuclear matrix proteins to be lamins A, B, C, the nucleolar protein B-
23/numatrin, residual protein components of core heterogeneous nuclear 
ribonucleoproteins (hnRNP) and matrins 3, 4, D-G, 12 and 13. Amongst the 
matrins, two were shown to be zinc- finger motif containing DNA-binding 
proteins. 
Recently, more and more proteins are being discovered to be present in 
the nuclear matrix but its precise composition is still a subject of ongoing 
research. Some examples of nuclear matrix proteins will be cited below. 
Because many protocols initially relied on harsh extraction conditions (e.g. 
high salt-containing buffers) to reveal the nuclear matrix, a lot of criticism 
emerged concerning the physiological relevance of the structures observed 
(Pederson, 1998; Pederson, 2000). But the retention of a more or less similar 
structure after fairly different treatment protocols became an important 
argument in favour of the biological validity of the concept of the nuclear 
matrix. 
With time, many different laboratories provided independent evidence 
of the existence of the nuclear matrix in vivo. For example, Bioluminescence 
Resonance Energy Transfer (BRET) was used to study the interaction of 
transcriptionally active proteins, including nuclear matrix proteins in living 
cells (Germain-Desprez et al., 2003). Importantly, chromatin was reported to be 
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effectively removed from nuclei at physiological ionic strength by 
formaldehyde crosslinking and nuclease digestion (Nickerson et al., 1997) and 
both DNA and histones could also be removed efficiently from the nucleus by 
nuclease digestion and the modification of primary amino groups with sulfo-
NHS (Wan et al., 1999). Again, these treatments left behind what is called 
nuclear matrix.  
Electron microscopic analyses carried out in the laboratory of Sheldon 
Penman were also seminal to the field. By using a protocol in which sharp 
increases in ionic strength in the extraction buffer were avoided a fine network 
of nuclear matrix filaments along with some dense bodies could be revealed on 
electronmicrographs. He was also the first to demonstrate that treatment with 
RNase A removed the core filaments, suggesting RNA's to be an integral part 
of these filaments (Fey and Penman, 1988; He et al., 1990; Nickerson and 
Penman, 1992; Penman, 1995). Finally, other variations of microscopy 
methods such as embedment-free electron microscopy (EF-EM) have 
overcome some limitations of heavy metal staining and aldehyde fixation. This 
technique was able to present a cellular scaffold as a purified, isolated, three-
dimensional network with various thicknesses of filaments. With the adaptation 
of immunocytochemistry to EF-EM, the nuclear matrix can now be better 
studied (Gajkowska and Wojewodzka, 2003).  
However, beyond this role as a scaffold and backbone that merely 
supports the nucleus, the nuclear matrix has also been assessed as a special 
nuclear compartment with specific functions in replication, transcription and 
RNA splicing. Examples to illustrate such functions are the lamins. These 
proteins not only sustain the nuclear envelope and participate in the formation 
of internal nuclear matrix filaments as structural proteins, but lamins can also 
be detected in replication foci speckles (Bridger et al., 1993; Moir et al., 1994). 
Using a truncated dominant negative form of lamin, it was found that 
coincident with the disruption of lamin organization, there was a dramatic 
reduction in DNA replication (Spann et al., 1997). Moreover, contrary to the 
commonly held view that replication begins at hundreds of dispersed nuclear 
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sites, studies done with primary fibroblasts showed that DNA synthesis was 
initiated at a limited number of foci that contain replication proteins, surround 
the nucleolus and overlap with lamin A/C structures (Kennedy et al., 2000). 
Similar to DNA replication, processes of transcription and splicing were 
also shown to occur within specific foci or speckles (Carter et al., 1993; 
Jackson et al., 1993; Xing et al., 1993; Xing et al., 1995). 
Interestingly, during apoptosis, the proteins of the nuclear skeleton 
components [term suggested by Razin which designates the nuclear lamina and 
the network of filaments supporting the internal nuclear matrix] are the first to 
be proteolytically cleaved. That, in turn, reinforces the concept that the nuclear 
skeleton is essential for maintenance of both the shape and the internal 
structural organization of eukaryotic cell nuclei. Several nuclear matrix 
proteins can serve as substrates for proteolytic cleavage during apoptosis and 
cleavage of lamin B, NUMA and nucleoporin TPR follow a specific temporal 
pattern (Dynlacht et al., 1999; Dynlacht et al., 2000). 
In addition, it has been proposed that transcription factors are recruited 
to the nuclear matrix facilitating interactions with regulatory DNA elements 
(Samuel et al., 1998) and chromatin-modifying enzymes have also been found 
associated with the nuclear matrix (Davie and Hendzel, 1994; Sun et al., 2001). 
As mentioned above, the exact composition of the high-salt-insoluble 
nuclear matrix compartment remains unclear. Besides containing exclusive and 
permanent matrix proteins (e.g. nuclear skeleton proteins), the nuclear matrix 
also contains proteins that are temporarily deposited there. These latter proteins 
are known to be regulated by posttranslational modifications induced by 
specific signalling cascades. For example, the promyelocytic leukaemia protein 
(PML) is a phosphoprotein found to be tightly associated with the nuclear 
matrix (Chang et al., 1995). In recent years, this protein has been extensively 
studied because of its role in causing acute promyelocytic leukaemia (APL). In 
this disease, the PML gene is disrupted by a translocation to the RARA gene on 
chromosome 17 resulting in aberrant expression of a fusion protein and 
disruption of PML bodies. PML is not only affected in leukaemia, but is 
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mislocalised and misregulated in solid tumours of various histological origins, 
indicating that PML and PML bodies might also be involved in the 
development of other tumour types (Zink et al., 2004). Loss of PML expression 
correlates with the invasiveness of malignant cells (Koken et al., 1995) and 
with tumour progression in prostate cancer, breast cancer and CNS tumours 
(Gurrieri et al., 2004).      
The following groups of proteins are found to partition between the 
nuclear matrix and the soluble compartments of eukaryotic cell nuclei are: 
1. Enzymes involved in DNA replication and postreplicative modifications 
e.g. DNA polymerase α, proliferating cell nuclear antigen (PCNA), etc 
2. Enzymes involved in transcription and splicing of messenger RNA and 
proteins of nuclear RNP-particles e.g. RNA-polymerase II 
3. Proteins of the mitotic apparatus such as NuMA and the CENPs B, C 
and F 
4. DNA-binding proteins 
5. Regulators of the cell cycle e.g. PML, cdk2 and cdc2 
6. Proteins involved in the control of chromatin dynamics e.g. 
histoneacetyl-transferase and histone diacetylase 
7. Receptors (e.g. oestrogen receptor) and receptor-binding proteins  
 
Gene-nuclear matrix associations are also involved in regulating cell- 
and tissue specific gene expression. In the differentiation of rat osteoblasts for 
example, dramatic changes in nuclear matrix protein patterns occurred during 
transitions from the proliferation to the ECM maturation stage and from ECM 
maturation to mineralization (Dworetzky et al., 1990). Finally, the composition 
of the nuclear matrix not only changes in the course of cell differentiation as 
exemplified above, but also during malignant cellular transformation. 
Alterations in nuclear structure including dramatic changes in morphology are 
a typical characteristic of most cancers. Since the nuclear structure is 
maintained predominantly by the nuclear matrix, it is logical to assume that 
alterations in nuclear shape or structure that occur with neoplastic 
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transformation are accompanied by changes in nuclear matrix composition or 
architecture, or both (Konety and Getzenberg, 1999). Examples of nuclear 
shape changes associated with cancer have been reviewed in (Zink et al., 2004).   
 
I.7. Aim of my work 
The aim of my work was to gain a better understanding of teneurin-1 
signalling and function. Using cell biological techniques, I assessed the model 
that teneurin-1 is cleaved in a Notch-like manner and that its intracellular 
domain translocates to the nucleus (see I.2). Furthermore, I was interested to 
investigate the involvement of the N-terminal domain of teneurin-1 in gene 
regulation and to characterize proteins that interact with it.   
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II. MATERIALS AND METHODS 
II.1 Vector information  
 
1. pCEP-Pu: (9.48 kb) provided by Prof. J. Engel, Biozentrum, University of Basel. 
This vector was used to clone cDNAs encoding the intracellular domain of teneurin-1 
"IDten-1" (1-300aa) and the putative full-length teneurin-1 "FLten-1" (1-2705aa) into 
the NotI / XhoI restriction sites. Sequencing of the putative full-length construct 
revealed that it contained a mutation that generated a premature stop codon at 2161 
bp, truncating the protein at 722 aa. This teneurin-1 cDNA encoding the protein with 
the premature stop codon was designated medium-length teneurin-1 "MLten-1" (1-
721aa). Site-directed mutagenesis was used to remove the premature stop codon to 
generate a cDNA that expresses full-length teneurin-1 (for details see II.11.). 
 
2. pCMV5-myc: (3.8 kb) provided by Yoshimi Takai, Osaka University Medical 
School, Japan. The vector already contained Ponsin-2 cDNA (Mandai et al., 1999) 
cloned into the EcoRI / SalI restriction sites. 
 
3. p-CMX: provided by Ronald M. Evans, San Diego. The vector already contained 
PML cDNA encoding the intact protein (560aa) (Kakizuka et al., 1991). 
 
4. pcDNA3: (5.4 kb) commercially available vector (Invitrogen). The amplified 
MBD1 PCR product was cloned into the HindIII and XhoI sites by Jacqueline 
Ferralli. 
 
5. pIND: (5.0 kb) commercially available vector (Invitrogen). The intracellular 
domain of teneurin-1 was cloned into the NotI/ XhoI sites by Doris Martin. This 
construct was used to transfect EcR-293 cells for the generation of stable cell lines 
(for details see II.19.). 
 
6. pQE30: (3.4 kb) commercially available vector (Qiagen) containing a 6xHis-tag.  
The PCR products corresponding to the first N-terminal 160 amino acids and the C-
terminal last 334 amino acids of teneurin-1 were cloned into the KpnI / SphI sites. 
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7. p123T: (3.0 kb) commercially available vector (MoBiTec). It was used for cloning 
of PCR products. Correct insert size was verified by digestion using XhoI and XbaI 
restriction enzymes and analysis by 1% agarose-gel electrophoresis.   
 
II.2 Bacterial Strains 
1. Escherichia coli M15[pREP4]. This strain contains the pREP4 plasmid to allow 
glucose-regulated expression of constructs cloned into the pQE vector. 
Transformation with pQE was done in the presence of kanamycin at 25µg/ml and 
ampicillin at 100µg/ml. 
  
2. Escherichia coli XL1-blue. recA- cloning strain used to host the ligation products 
in pKS (BlueScriptII KS+), p123T or pQE. Transformation was done in the presence 
of ampicillin at 100µg/ml or kanamycin at 25µg/ml, depending on the vector used.  
 
3. Escherichia coli DH10. This strain harbours the Bacterial Artificial Chromosome 
RP11-424C23, which was ordered from CHORI (Children's Hospital Oakland 
Research Institute). Transformants were selected by plating on plates containing 
chloramphenicol at 20µg/ml. 
 
II.3 Extraction of plasmid DNA 
1. Small scale purification (Mini-Prep): DNA extraction was performed using the 
commercial kit from Qiagen "QIAprep Spin Miniprep Kit" according to the 
manufacturer's instruction. Mini-preps were done with the overnight culture grown in 
2ml LB medium containing the appropriate antibiotic(s). 
 
2. Medium scale purification (Midi-Prep): Larger scale DNA extraction was 
performed using the commercial kit from NUCLEOBOND "Nucleobond AX PC100" 
according to the manufacturer's instructions. Midi-preps were done with the overnight 
culture grown in 100ml LB medium containing the appropriate antibiotic(s). 
 
3. DNA isolation from BAC clones: A rapid alkaline lysis miniprep method was 
used, consisting of a modification of a standard Qiagen-Tip method. All 
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recommendations on how to handle the clones were taken from: 
http://bacpac.chori.org/home.htm 
 
II.4 Ligation 
Rapid ligation reactions used the molar ratio mixture of 3:1 (insert:vector) and were 
done using the Rapid DNA Ligation Kit (Roche) based on the manufacturer's 
instructions. All reactions had a final volume of 20µl. 
 
II.5 Transformation of bacteria 
1. Preparation of competent cells (Ariane Minet, PhD thesis, 2000) 
• inoculate 10ml LB-medium with a single colony of E.coli XL Blue and grow at 
370C o/n 
• transfer o/n culture into 100ml warm LB-medium and grow at 370C until OD600= 
0.94 
• centrifuge 2 x 50ml bacteria culture at 2500g (4500rpm Sorval minifuge) at 40C 
for 5 minutes 
• carefully resuspend the pellet in 2 x 10ml ice-cold solution I and incubate on ice 
for 10 minutes 
• centrifuge at 2500g for 5 minutes 
• carefully resuspend the pellet in 2 x 2ml ice-cold solution II 
• aliquot (50µl or 100µl) and freeze immediately at -700C for storage  
 
Solution I: (pH 5.8) 30mM KOAc, 50mM MnCl2, 100mM RbCl2, 10mM CaCl2 and 
15% glycerol - sterile filter (0.22µm) 
Solution II: 10mM MOPS pH 7.0, 75mM CaCl2, 10mM RbCl2 and 15% glycerol - 
sterile filter (0.22µm) 
 
2. Transformation 
• thaw a vial containing 50µl of competent XL-Blue/Gold cells on ice 
• add the entire ligation reaction (see II.4.) directly to the competent cells  
• incubate on ice for 30 minutes 
• heat shock at 420C for 1.5 minutes 
• put back on ice for 2 additional minutes 
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• plate cells on LB-plates containing the appropriate antibiotics (for calculation of 
the concentration consider approximately 20ml per plate)  
• incubate plates at 370C overnight 
Note 1: If screening by blue/white selection, allow the LB plates to reach room 
temperature and only then add both IPTG (10µl of 100mM stock) and X-gal (30µl of 
2% solution). Note 2: If propagating plasmid DNA, follow the same protocol as above 
but instead of adding the ligation reaction to the competent cells, add 1ng of the DNA 
to be propagated. 
 
II.6. DNA digestion 
Plasmid DNA and PCR products were digested in a buffer containing the adequate 
restriction enzyme(s), double-distilled water and BSA, if required. Incubation time 
and temperature varied according to the enzyme(s) used. Samples were analyzed by 
running an aliquot of the digestion products in an agarose gel containing 0.5µg/ml of 
ethidiumbromide, followed by visualization with a UV transilluminator. 
 
II.7. Agarose gel eletrophoresis 
Agarose gels were prepared in various concentrations (0.7%, 0.8% and 1.0%) by 
weighing agarose (Agarose Electrophoresis Grade Ultra Pure - Invitrogen) in TBE 
buffer and boiling the mixture in a microwave oven. Before casting the gel 
ethidiumbromide was added to the mixture as it had cooled down. Loading-buffer was 
added to the samples and gels were run at 50 to 100V for approximately one hour. To 
visualize the DNA, an UV transilluminator was used. 
 
10x TBE buffer: 1M Tris-HCl; 1M boric acid and 20mM EDTA. 
6x loading buffer: 0,25% bromophenolblue; 0,3% cyanol xilene and 30% glycerol. 
 
II.8. Isolation and Purification of DNA fragments from agarose gels  
The DNA fragments were excised from the gel using a razor blade under UV light. 
The DNA in the gel pieces was extracted following the instructions of the Qiagen 
"QIAquick Gel Extraction Kit". 
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II.9 DNA sequencing 
DNA sequencing was a service provided in house and was carried out using 
BigDyeTerminators (Applied Biosystems) with a GeneAmp PCR system 9700 
thermocycler (Applied Biosystems). Samples were processed in an ABI PRISM 3700 
DNA Analyser (Applied Biosystems).  
 
II.10 Polymerase Chain Reaction (PCR) 
PCR reactions consisted of 1µl of DNA template, 0.4µl of polymerase high fidelity 
(Expand High Fidelity PCR System) or long template (Long Template Polymerase) 
both from Roche, 1µl of a 10mM dNTPs mixture (Eppendorf), 2.5µl of a 10x MgSO4 
containing buffer (Roche), 1µl of each primer (20mM) and bi-distilled water to a final 
volume of 25µl. Reactions were run in an Eppendorf Mastercycler Personal as well as 
a Gradient PCR machine (Eppendorf). 
For most of the reactions, the PCR was programmed as follows, unless otherwise 
indicated:  
1) 940C  0:03:00 
2) 940C  0:00:30 
3) 550C  0:00:30 
4) 720C  0:03:00 
5) repetition of steps 2 to 4 for 30 cycles 
6) 040C until analyses  
Note: For nested-PCR's the products of the initial PCR reaction were diluted 1:10 and 
used as template for a subsequent PCR. 
 
II.11 Cloning 
1. Correcting the premature stop codon found in the pCEP vector containing the 
so-called "Full-length teneurin-1 # 5" 
The pCEP-vector containing full-length teneurin-1 # 5 (Minet; not published) was 
sequenced and found to have a mutation generating a stop codon at 2161 bp, 
truncating the protein at 722aa. Thus the original construct encoded a teneurin-1 
protein with a truncation just after the 7th EGF-like repeat. The cDNA region 
containing the premature stop codon was excised using PmlI and NotI and a series of 
PCRs were performed in order to correct the mutation by site-directed mutagenesis.  
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After sub-cloning the 2.5bp fragment back into the pCEP vector using the PmlI and 
Not I restriction sites, sequencing was used to identify clones where the mutation had 
been successfully removed. Subsequently, the clone expressing the truncated protein 
was termed medium-length (ML) teneurin-1, as the protein encoded roughly half the 
size of the full-length (FL), and the new corrected construct was defined as FL. 
Briefly, the region to be corrected was used as a template to design primers that would 
generate a sequence where the corresponding stop codon was exchanged. In the first 
PCR reaction amplified, primer forward A was used with primer reverse D to amplify 
a 2618bp fragment and in the second PCR reaction primer forward C was used with 
primer reverse B to amplify a 380bp fragment. Finally, the last PCR reaction put both 
products together using primers A and C and amplified a fragment of approximately 
2500bp which was sub-cloned back into the pCEP vector and checked if it contained 
the right sequence. The following sequence correction was made: 
2158GGGTAGTGT2167 into 2158GGGAAGTGT2167
721K*E723 into 721KCE723  
Primers used are defined as follows: A (5' CTGCACTCACACTTCCCGTCTTTGCA 
3'); B (5' AAAGACGGGAAGTGTGAGTGCAG 3'); C (5'AGGTGTTCCGTCTATT 
GC3'); D (5' AGAGCTCGTTTAGTGAACCG 3'). 
 
2. Cloning of putative splice variants of the XM_039676 gene 
To confirm if the different bands observed in the nested PCR were spliced forms of 
the XM_039676 transcript, they were cloned and sequenced using the following 
protocol: 
• excise band(s) from gel and purify according to the standard protocol from 
QIAquick Spin Handbook (Qiagen) 
• ligate 7.5µl of the insert directly into 0.5µl of p123T vector 
• transform into XL-Gold competent cells and seed in LB+ after addition of X-gal 
and IPTG following standard protocol 
• grow colonies overnight. Check for the presence of the insert by digestion with 
XhoI and XbaI enzymes 
 
II.12 RNA extraction for Microarray Analysis 
Before starting to work with RNA, all materials were treated with DEPC water to 
inactivate RNAses. For this experiment 15ml Corex tubes (no8441) were treated 
Samantha Michele Nunes Radimerski 48
Materials and Methods 
overnight with DEPC water, followed by autoclaving. Total RNA was extracted from 
10cm cell culture dishes using the following protocol: 
• remove medium and wash cells once with PBS- 
Homogenization:  
• lyse cells by adding 5.5 ml Trizol-reagent (Life Technologies) directly into the 
dish. Immediately pipette up and down several times 
Phase Separation:  
• incubate sample at RT for 5 minutes 
• add 1.1 ml of Chloroform (do one sample at a time) 
• shake by hand for 15 seconds 
• change to DEPC-treated Corex tubes 
• incubate sample at RT for 2 - 3 minutes 
• using the Sorvall SS-34 rotor, centrifuge samples with 12000g at 2 - 80C for 15 
minutes  
• keep oil phase for protein, proceed with the aqueous phase 
RNA Precipitation: 
• transfer aqueous phase to new Corex tubes 
• add 2.75 ml of isopropyl alcohol and mix  
• incubate sample at RT for 10 minutes 
• using the Sorvall SS-34 rotor, centrifuge samples with 12000g at 2 - 80C for 12 
minutes  
RNA Wash: 
• remove supernatant            
• wash pellet by adding 6 ml of 75% ethanol                                 
• vortex and freeze at -200C if stopped here, otherwise only vortex 
• using the sorvall SS-34 rotor, centrifuge samples with 7500g at 2 - 80C for 5 
minutes  
Redissolving the RNA: 
• dry RNA pellet (air dry) for 10 minutes (no centrifugation) 
• dissolve RNA in 100 µl RNAse free water by pipetting the solution a few times up 
and down  
• incubate at 55 - 600C for 10 minutes      
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• store at -200C overnight until used or proceed for RNA re-purification using RNA 
Clean up following manufacturer's protocol (RNAeasy; Qiagen). 
Note: RNA concentration should be > 1.5µg/µl with an A260:280 ratio > of 1.9 
determined using either 10mM Tris or TE pH 7.5 
 
II.13 cDNA generation 
cDNA for mRNA expression analysis by RT-PCR was generated using either random 
or oligo-dT primers and ThermoScript (15U/µl) from the ThermoScriptTM RT-PCR 
System (Invitrogen) following instructions of the manufacturer. 
 
II.14 Microarray analysis 
Microarray hybridisation and assistance with data mining was a service provided by 
the institute. Briefly, total mRNA (>5µg) was extracted from cells that stably express 
IDten-1 and from vector control cells. The mRNA was reverse-transcribed into cDNA 
using the genechip one-cycle cDNA Kit from Affymetrix and then in vitro transcribed 
into cRNA in the presence of biotinylated UTP using the Affymetrix IVT labelling 
Kit. After fragmentation, the antisense cRNA samples were hybridised to Affymetrix 
U133A GeneChips, washed, stained with streptavidin-phycoerythrin (Molecular 
Probes) and scanned in an Affymetrix GCS 3000 scanner. Expression data were 
generated using the RMA package from Bioconductor (Irizarry et al., 2003) and 
imported into GeneSpring 6.2 (Silicon Genetics, Santa Clara, CA, USA). In total, 12 
chips were used to produce data in duplicate and from separate days, for the statistical 
analyses. The experiment consisted of a time course of 0, 6, 12 and 24 hours after 
induction of IDten-1 protein expression with ponasterone. Samples in which IDten-1 
expression was induced were compared to control samples expressing the empty 
pIND vector. Genes were pre-filtered whose expression value was ≥ 100 units in at 
least one condition with a fold change of ≥1.5 relative to the time point 0. Fold change 
lists were combined and genes were further considered that passed at least a 1-Way 
ANOVA (p ≤ 0.05). To minimise the effect of multiple testing errors, a Benjamini and 
Hochberg correction to the ANOVA was performed. A Tukey post-hoc test was then 
applied in order to identify the origin of the significant effects within the time course. 
The lists containing the genes that passed the Tukey post-hoc test are not shown in 
this thesis. Moreover, a 2-Way ANOVA test was applied to refine the analysis. Ho 
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(null hypothesis) was that treatment with ponasterone has no effect on the kinetics of 
gene expression over time. This hypothesis was rejected when the interaction P-value 
was ≤ 0.05. Finally, genes present in the 1-Way and in the 2-Way ANOVA lists were 
functionally classified using the following website:  http://fatigo.bioinfo.cnio.es/. 
FatiGO stands for Fast transference of information using Gene Ontology (Ashburner 
et al., 2000) and is a web-based interactive tool that classifies an input text file 
containing, for example, affymetrix probeset IDs into categories according to 
biological processes, molecular function or cellular components. This tool was 
developed in the Bioinformatics Department of the Spanish National Cancer Center. 
 
II. 15 Luciferase Assays 
Reporter assays were performed using a commercially available Mercury Pathway 
Profiling detection system (Clontech) that allows expression of luciferase under the 
control of the p53 promoter. The Luciferase Assay System is commercially available 
from Promega. Briefly, U2OS and CEF cells were seeded in 6 well dishes and were 
transfected after 12 hours either with the IDten-1 plus pSV-β-galactosidase or with 
the vector control plus pSV-β-galactosidase. pSV-β-galactosidase is used to 
normalize samples as internal control. After 24 hours cells were lysed in a special 
reporter luciferase buffer and processed as described in (Bagutti et al., 2003). 
  
p53response element Promoter Reporter
activation.
Promoter Reporter
Negative control
Stimulus
 
  
II.16 Antibody generation 
N-and C-terminal sequences of the chicken teneurin were used to derive primers to 
amplify PCR products (see details for N-terminal primer-set sequences and C-
terminal primer-set sequences below). PCR products were cloned into the 6XHis-Tag 
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pQE-30 expression vector (Qiagen) using the KpnI and SphI restriction sites. This 
vector was transformed in XL-blue competent cells in order to propagate the DNA. 
The isolated purified DNA was then used to transform the M15 [pREP4] E.coli strain. 
Expressed fragments were transformed into bacteria to yield recombinant protein, 
which was purified on a Nickel column (Qiagen). Purified recombinant protein 
fragments were injected into 4 rabbits (RCC Ltd, Switzerland), giving rise to two 
antisera against the N-terminus and two antisera against the C-terminus of teneurin-1 
(termed anti-A, anti-B, anti-C anti anti-D, respectively). For sake of simplicity, the 
antibody termed anti-B was designated anti-N in the subsequent work. All antisera 
were purified on a protein-A column (Affi-Prep Protein A Matrix- BIO-RAD) in 
order to concentrate immunoglobulins of the IgG subtype (see II.17 for details). 
Constructs were amplified using the following primer sets: 
01-N terminus (first 160aa):  
CT_Nt_SphI_5 (5' ATTCAGGCATGCATGGAGCAGATGGACTGC 3') 
CT_NtS_Kpn_3 (5' GCTCCCGGTACCGTCATTCTCCCCATCAGAC 3') 
 
02-N terminus (first 300aa): 
CT_Nt_SphI_5 (5' ATTCAGGCATGCATGGAGCAGATGGACTGC 3') 
CT_NtL_Kpn_3 (5' ACTCAGGGTACCGCACTTCCAGTTGCAACAC 3') 
 
03-C terminus (last 334aa): 
CT_Ct_SphI_5 (5' CCAAACGCATGCATATGGAAACACCTGAATGC 3') 
CT_Ct_KpnI_5 (5' CGTAGGTACCTTACCTTCTGCCTATTTCAC 3') 
 
Anti-teneurin-1 antibodies and antibodies from commercial sources are: 
       Antibody Company/supplier  WB dilution IF dilution 
HA (12CA5) Roche 1:100 1:100 
PML (PG-M3) Santa Cruz 1:1000 1:1000 
Myc (9E10) Santa Cruz 1:1000 1:1000 
β-galactosidase 3prime5prime not tested 1:500 
BrdU PharMingen not tested 1:500 
Acetyl-histone H4 Upstate 1:100 1:100 
Flag (M2) Stratagene 1:1000 1:1000 
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Ponsin Upstate 1:1000 1:300 
MBD1 Abgent 1:100 1:300 
phospho-p53 Santa Cruz 1:500 not tested 
phospho-MAPK cell signaling 1:1000 not tested 
Tubulin Sigma 1:200 not tested 
N-terminus teneurin-1 RCC 1:300 1:300 
C-terminus teneurin-1 RCC 1:300 1:300 
goat anti rabbit  
FITC-conjugated 
Alexa not applicable 1:1000 
goat anti mouse 
rhodamine-conjugated 
Alexa not applicable 1:1000 
 
 
II.17 Affinity Chromatography of Teneurin-1 antibodies 
Affi-Prep protein A (BIO-RAD) consists of highly purified protein-A covalently 
coupled to a polymer matrix gel and was used to bind immunoglobulins, thereby 
enriching the polyclonal anti-teneurin-1 antibodies. The system used MAPs buffer 
that increases protein-A's capacity to bind IgGs and IgMs from many different 
species. The following antibodies were purified using this method: anti-A and anti-B 
(both against the N- terminus of teneurin-1) plus anti-C and anti-D (both against the 
C-terminus of teneurin-1). In addition, the pre-immune serum from rabbit B, which 
was used as control in immunostaining experiments, was also purified.  
Purification protocol based on manufacturer's instructions and (Harlow and Lane, 
1999) 
• dilute serum which contains approximately 10mg/ml of polyclonal antibody in 
binding buffer in a ratio of 1:2 (serum:buffer)  
• filter diluted serum through a 0.45 or 0.8µm filter before loading onto the column 
(with a syringe adaptor) 
• pack appropriate volume of beads onto the column (calculate approximately 1ml 
of beads for 1ml of serum before dilution). Bead loading capacity for rabbit IgG is 
9-16 mg/ml and 5-7 mg/ml for IgM 
• equilibrate column applying binding buffer until the eluate reaches the pH of 9.0 
• load the serum (diluted and filtered) onto the column 
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• let it flow through very slowly, collect the flow through 
• pass the flow through over the column again 
• wash with 10-15 bead volumes of binding buffer (apply 0.5ml at a time) until the 
OD280 has decreased 
• elute with 15 bead volumes of elution buffer (apply 0.5ml at a time) 
•  collect the eluate in 0.5ml volumes in eppendorf tubes containing 1/10 column 
volume of 1M Tris-HCl pH 8.0. Mix gently 
• identify the IgG-containing fractions by absorbance reading at 280nm (1OD280 = 
approximately 0.8mg/ml). Combine antibody-containing fractions, run 2µg of 
total protein on a SDS-PAGE gel and stain with Coomassie blue. Pure heavy and 
light chain bands should be seen. 
 
MAPs buffer: Binding Buffer: (3.2M NaCl, 1.6M Glycine pH 9.0). Elution Buffer: 
(100mM NaCitrat pH 3.0)   
 
II.18 Cell culture 
Primary cell culture of Chicken Embryo Fibroblasts (CEF): Fertilized eggs were 
grown in a humidity and temperature-controlled incubator until the desired 
developmental stage was reached. CEF cells were derived from 11-day-old embryos 
using the following protocol:   
• rinse eggshell with 70% ethanol and break it open  
• transfer embryo directly into a 10cm plate containing a physiological solution 
such as PBS- and immediately dissect the head off 
• transfer the body to a clean dish and dissect the skin with sterile forceps 
• place the skin in a Falcon tube containing 10ml of a trypsine/EDTA solution (T/E) 
• incubate at 370C for one hour to facilitate cell dissociation 
• pass cells through a cell strainer (Falcon, nylon 70µm) and pipette up and down a 
few times before seeding them into a new 10cm dish.  
• cultivate cells in DMEM containing 10% FCS 
• split cells at 70% confluence  
 
Cos-7 (green monkey kidney), HT1080 (human fibrosarcoma), U2OS (human 
osteosarcoma) cells and HEK 293 (human embryonic kidney) cells: All 
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immortalized cells lines described above were maintained in DMEM with the addition 
of 10% FCS, unless otherwise specified. Cells were grown in 10cm cell culture dishes 
and always split at 80% confluence. 
 
EcR-293 cells (Invitrogen): commercially available from Invitrogen. EcR-293 cells 
stably express the ecdysone receptor from the pVgRXR vector. They were maintained 
in DMEM with the addition of 10% FCS and 25µg/ml of zeocin.  
 
II.19 Generation of stable cell lines  
Briefly, EcR-293 cells were transfected with the pIND vector containing the construct 
of interest (encoding IDten-1, MLten-1 or FLten-1). For the current study an ecdysone 
inducible system was used to generate stable cell lines designated EcR-IDten-1, 
MLten-1 or FLten-1 (EcR-FLten-1 was generated by Marianne Brown-Luedi). As 
control, stable cell lines containing the empty vector were also generated, and termed 
“pINDvector”. In order to induce protein expression, a synthetic analogue of ecdysone 
(ponasterone) was added to the medium at a final concentration of 10µM. To generate 
inducible stable cell lines expressing the various forms of teneurin-1 this protocol was 
followed: 
• Thaw and cultivate EcR-293 cells in DMEM + 10%FCS supplemented with 
25µg/ml of zeocin 
• Cultivate cells for a few generations before transfection 
• Transfect cells with pIND vector containing the gene of interest (see II.21.) 
• The following day, add G-418 (400µg/ml) to the media in order to select for the 
transfected cells 
• Cultivate cells until they reach 70% confluency and then split cells at several 
dilutions into 10cm plates in order to obtain growth of single clones. (suggested 
dilutions are 1:40, 1:60, 1:120, 1:240, 1:480) 
• Once growth of single colonies is visible, pick and transfer each individual colony 
to a 24-well plate.  
• Cultivate clones further and assay for protein expression (e.g. by Western blotting)   
Note: Positive clones are propagated further and stocks are frozen. 
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II.20 Splitting, freezing and thawing of cells    
Splitting: At 80 % confluence, cell layers were rinsed once with PBS- (heated to 370C 
in a water bath) and trypsinised with a solution consisting of a mixture of 
trypsin/EDTA to disrupt cell-cell and cell-substratum interactions. The trypsin was 
inactivated by the addition of DMEM to the plate.   
Freezing: cells were treated as above, and collected by centrifugation. The pellet was 
resuspended in cold freezing media (normal medium supplemented with FCS and 
DMSO). Recipe for 10ml: 6ml DMEM, 3ml FCS and 1ml DMSO. Cells were then 
transferred into cryo-tubes (Nunc), placed in a Styrofoam box and frozen at -800C. 
Note: for long-term storage cryo-tubes should be transferred to liquid nitrogen. 
 
Thawing: cells were thawed in a water bath at 370C and quickly transferred to a 
Falcon tube containing 10 - 15 ml of DMEM + 10% FCS. After centrifugation the 
supernatant was discarded and the cell pellet was resuspended in DMEM +10%FCS. 
Cells were seeded into cell culture dishes and grown in an incubator at 370C + 5% 
CO2. 
 
II.21 Transfection of plasmid DNA into cells 
Exogenous DNA was delivered into cells with the lipid based FuGENE 6 transfection 
reagent (Roche) using the ratio 3:1 (µl reagent/µg DNA) following the manufacturer's 
procedure. 
 
II.22 Protein extraction from cell culture 
Cells were cultivated until they reached 80% confluence. Medium was removed and 
after one wash with PBS- the cells were directly lysed in the dish on ice for several 
minutes either in RIPA buffer (50mM Tris-HCl pH 8.0, 150mM NaCl, 1% NP40, 
0.5% deoxycholic acid, 0.1% SDS, 50mM NaF and 0.5mM Na3VO4) or NP40 buffer 
(50mM Tris-HCl pH 7.4, 250mM NaCl, 5mM NaF, 5mM EDTA, 0.1% NP40 
complemented with protease inhibitors cocktail from Roche). With a cell scraper, the 
cell lysate was transferred to an eppendorf tube and centrifuged at 11000rpm for 5 
minutes at 40C to pellet cell debris. The supernatant was kept at -200C until use. 
Samantha Michele Nunes Radimerski 56
Materials and Methods 
Protein concentration in each lysate was determined using the BIO-RAD Protein 
Assay Kit following their specifications. 
 
II.23 Western blotting 
All Western blots described in this thesis used the minigel system from BioRad and 
were run in a BIO-RAD 3000/300 or a Pharmacia Electrophoresis EPS 3500 power 
supply. Polyacrylamide Gel Electrophoresis (PAGE) gels were transferred to PVDF 
membrane using a Semi-Dry blotting apparatus from Millipore.  
• Pour the desired percentage of acrylamide solution using the BioRad minigel 
system and allow to polymerise 
• place the polymerised gels into the running chamber, fill with running buffer and 
load samples into wells  
• run each gel applying 25mA for the stacking front and increase to 35mA at 
constant currant as soon as the samples reach the separating front 
• if no transfer to PVDF membrane is needed, stain gel with GELCODE Blue Stain 
(Pierce) 
• if needed, transfer proteins from mini-gel to PVDF membrane using the semi-dry 
blotting apparatus  
• first soak 6 pieces of Whatman paper (3MM) in blotting buffer and place 3 pieces 
onto the anode side of the apparatus 
• moisten the PVDF membrane for one minute in methanol and then leave it in 
blotting buffer until the “sandwich” is ready to be assembled 
• transfer the membrane on top of the Whatman papers  
• carefully transfer the acrylamide gel on top of the membrane 
• complete the "sandwich" by placing the additional 3 pieces of Whatmann paper on 
top of everything. (use a glass rod to roll over the surface for the removal of air 
bubbles) 
• apply a constant current of 45mA per minigel for 1 to 2 hours depending on the 
size of the protein to be transferred   
• stain the gel with amidoblack (0.1% amidoblack, 40% isopropanol, 1% acetic 
acid) and take a picture of the transferred proteins 
• block the membrane with 3% skin-milk in TBS-T for one hour 
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• incubate primary antibody at the appropriate dilution in blocking buffer for one 
hour at RT or 40C overnight in a humid chamber  
• wash the membrane 3x in TBS-T (10 minutes each) 
• incubate the secondary antibody for 45 minutes at RT  
• wash as above and incubate the membrane with ECL detection solution 
(Amersham Life Science) for 1 minute, then drain the excess ECL and place the 
membrane between two pieces of transparent plastic inside the film cassette 
• in the dark room, expose a film on top of the membrane and develop the film  
 
Running gel: 2.5ml of lower buffer, adequate volume of acrylamide from a 30% 
solution (BioRad), 30µl of ammonium persulfate (20% ammoniumpersulfate w/v), 
10µl of TEMED (Fluka) and distilled water up to 10ml. 
Stacking gel: 1.25ml of upper buffer, 0.5ml of acrylamide from a 30% solution 
(BioRad), 15µl of ammonium persulfate (20% ammoniumpersulfate w/v), 10µl 
TEMED (Fluka) and distilled water up to 5ml. 
 
 
percentage of separating gel       3%    5%    6%   7.5%  10%  12.5%  15%  20% 
acrylamide (30%) in ml              1.0    1.7    2.0     2.5     3.3      4.2      5.0    6.7 
 
Blotting buffer: 48mM Tris/HCl pH 9.2, 39mM glycine, 1.3mM SDS, 20% methanol 
10x Running buffer: 250mM Tris/HCl, 1.9M glycine and 35mM SDS 
4x Loading buffer: 200mM Tris pH 6.8, 4% SDS, 17.4% glycerol and 2.8M β-
mercaptoethanol 
4x Lower buffer: (pH 8.8) 1.5M Tris/HCl and 13.9mM SDS 
4x Upper buffer: (pH 6.8) 0.5M Tris/HCl and 13.9mM SDS 
 
II.24 Immunofluorescence 
For the visualization of cells by immunofluorescence, cells were seeded onto special 
35 mm 4-well dishes (Greiner). After approximately 12 hours, the general protocol 
described below was followed: 
• transfect cells with desired constructs 
• after approximately 24 hours, aspirate the medium 
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• rinse cells once with PBS- 
• fix cells with 4% paraformaldehyde in PBS- for 15 minutes at 370C  
• if cells need to be permeabilized (e.g. for nuclear staining) incubate with 0.1% 
Triton X-100 in PBS- for 5 minutes 
• then rinse two times with PBS-/ otherwise rinse three times with PBS-  directly 
after the paraformaldehyde fixation 
• block with 3% goat serum in PBS- for 15 minutes (1ml per dish at RT) 
• apply first antibody diluted in blocking buffer (use 70µl  per well) 
• leave for one hour at RT or 40C overnight in a humid chamber 
• wash 3 x with PBS- (10 minutes each) 
• apply secondary antibodies goat anti-rabbit FITC conjugated and/or goat anti-
mouse rhodamine conjugated at 1:1000 (70µl per well) note: when  staining of 
DNA is desired, Hoechst can be diluted (1:200 - 1:500) in the solution together 
with the secondary antibodies.   
• leave one hour in the dark 
• wash as before 
• carefully aspirate each well  
• apply 10µl mounting medium (Moviol, from Calbiochem) per well 
• carefully place a coverslip on top of each well and avoid air-bubbles 
• store in the dark at 40C for a while (one hour) until visualization by microscopy 
 
II.25 Immunoprecipitation and co-immunoprecipitation 
1. Co-immunoprecipitation from cell culture extracts 
The following protocol was used: 
• Cos-7 cells were plated in a 6 well dish and transfected with IDten-1 and ponsin 
• after 24 to 48 hours wells containing approximately 2.5x106 cells each were 
frozen on dry ice, thawed and scraped in 300µl of PBS- complemented with 
proteinase inhibitors (complete cocktail tablets from Roche) 
• centrifuge cell extract at 14'000rpm, discard pellet containing debris and proceed 
with supernatant 
• add 150µl RIPA buffer to the supernatant to obtain a final volume of 450µl 
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• add 9µl (approximately 6 µg) of anti-N antibody. As control, one can add to a 
parallel sample an unrelated antibody (in this case the pre-immune serum of the 
anti-N antibody)  
• rotate cell extract for 90 minutes at 40C 
• add 30µl of protein-A Sepharose beads (4 Fast Flow; Amersham) pre-washed in 
RIPA buffer. The specificity of the antibody for the protein was checked by 
incubating a part of the sample with beads only. This step ensures that the protein 
of interest in not being pulled down by the beads, but only by the antibodies. 
• rotate for 60 minutes at 40C 
• collect beads by centrifugation, take an aliquot of the supernatant (unbound 
fraction) 
• wash beads 2x with PBS- 
• add 50µl of SDS-PAGE sample buffer to the beads, boil (shake occasionally) for 5 
minutes at 950C 
• pellet the beads by centrifugation in a mini-centrifuge 
• analyze samples by immunoblotting 
 
2. Immunoprecipitation of endogenous teneurin-1 
Brain, heart and liver tissues were dissected from an E17 embryo and processed as 
follows:  
• disrupt tissues on ice in an dounce homogenizer in RIPA buffer with 15 to 20 
strokes using a tight pestle 
• transfer homogenate to an eppendorf tube and centrifuge at full speed for 5 
minutes at 40C ; proceed with the supernatant 
• measure protein concentration with a Bradford assay 
• take the equivalent to 500µg of total protein and complete to a final volume of 
500µl with RIPA buffer.  
• pre-clear lysate with protein-A sepharose beads for 20 to 30 minutes at 40C 
• spin beads down using a mini-centrifuge. Discard them and to the supernatant, add 
6µg of anti-N antibody. Rotate on a rotating device overnight at 40C 
• next day, add 40µl of protein-A beads washed in RIPA buffer to precipitate the 
immunocomplexes and rotate for additional 4 hours at 40C 
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• spin beads down using a mini-centrifuge and take an aliquot of the supernatant 
(unbound fraction) 
• wash beads 3x with PBS- 
• add 50µl of SDS-PAGE sample buffer to the beads, boil for 5 minutes at 950C 
• collect beads by centrifugation in a mini-centrifuge 
• analyse samples by immunoblotting. Note: Because the anti-N antibody was used 
both for immunoprecipitation and detection, incubation with a secondary antibody 
was replaced by incubation with protein A-HRP (1:2500) from ICN/CAPPEL 
instead.   
 
II.26 Preparation of the nuclear matrix 
1. Immunofluorescence: The methodology described in Nickerson et al. was 
followed (Nickerson, 1998). Note: Prepare three times the amount of extraction buffer 
as compared to the cytoskeleton and digestion buffers. 
Cos-7 cells were seeded into four-well (35/10mm; Greiner) immunofluorescence 
dishes in DMEM 10% FCS. At 70% confluence cells were co-transfected with: IDten-
1 plus MBD1 or IDten-1 plus PML. Approximately 24hs later, cells were washed 
twice in PBS- and further treated as follows: 
• on ice, extract cells by applying 70µl/well of cytoskeleton buffer for 3-5 minutes. 
This step removes soluble cytoplasmic and nucleoplasmic proteins 
• on ice, apply 70µl/well of extraction buffer for 5-7 minutes. This step removes 
histone H1 and cytoskeletal proteins 
• treat dishes with 70µl/well of digestion buffer (310C; 30-50 minutes). This step 
removes the DNA and remaining histones 
• wash preparation twice with 70µl/well of extraction buffer (5 minutes per wash)  
• fix with 100µl/well of 4% paraformaldehyde (>20 minutes) 
• wash dishes three times in PBS- (10 minutes each)  
• block with 1ml per dish of 3% goat serum in PBS- (15 minutes) 
• incubate each well with 70µl of blocking buffer containing the primary antibodies 
diluted: anti-N(1:350), anti-PML(1:100), anti-MBD1(1:300), anti-PISN(1:300). 
Treat overnight at 040C 
• wash dishes as before 
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• incubate each we`ll with 70µl of blocking buffer containing the secondary 
antibodies diluted: goat anti-rabbit FITC conjugated and goat anti-mouse 
rhodamine conjugated (1:1000). Treat for 1h in the dark at room temperature. To 
check if the treatment removed heterochromatic DNA stain with Hoechst (1:200) 
simultaneously with the secondary antibody. Staining should be negative. 
• wash dishes as before and mount coverslips with 10µl/well Moviol (Calbiochem). 
Leave in the dark until analyses. 
 
Cytoskeletal Buffer 
Aliquots stored at -200C: 
10mM PIPES pH 6.8, 300mM sucrose, 100mM NaCl, 3mM MgCl2, 1mM EGTA 
To be added just prior to use:       
0.5% Triton X-100, 80u/ml RNAseOUTTM Ribonuclease inhibitor (Invitrogen), 
0.2mg/ml PMSF 
note: other protease inhibitors except for EDTA can be added if proteolysis is 
suspected. 
 
Extraction Buffer 
Aliquots stored at -200C: 
10mM PIPES pH 6.8, 250mM ammonium sulfate, 300mM sucrose, 3mM MgCl2, 
1mM EGTA 
To be added just prior to use:       
80u/ml RNAseOUTTM Ribonuclease inhibitor (Invitrogen), 0.2mg/ml PMSF 
 
Digestion Buffer 
Aliquots stored at -200C: 
10mM PIPES pH 6.8, 300mM sucrose, 50mM NaCl, 3mM MgCl2, 1mM EGTA 
To be added just prior to use:       
0.5% Triton X-100, 80u/ml RNAseOUTTM Ribonuclease inhibitor (Invitrogen), 
0.2mg/ml PMSF, 200u/ml RQ1 RNase-Free DNase (Promega) 
 
Triton Stock: 10%(w/v) Triton X-100. This is a 20x stock solution which is frozen in 
aliquots at -200C. 
PMSF Stock solution is 20mg/ml in isopropanol, stored at room temperature. 
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2. Western blotting: The methodology described in Lee and Skalnik was followed 
(Lee and Skalnik, 2002). 
Cos-7 cells were plated in 6 well dishes in DMEM 10% FCS. At 70% confluence 
cells were transfected with PML and co-transfected with IDten-1 and MBD1. 
Approximately 24hs later, cells were fractionated as follows: 
• remove supernatant and wash twice with cold PBS- 
• add 200µl CSK buffer complemented immediately before use with proteinase 
inhibitors, DTT and triton (see concentrations below) 
• leave on ice in a shaking device for 5 minutes 
• spin down at 5000g for 3 minutes 
• keep supernatant (corresponds to the soluble fraction) to be loaded onto the gel 
later 
• resuspend pellet in digestion buffer which is composed of CSK buffer added by 30 
units of RQ1 RNase-Free DNase (Promega) (volume to be added should be tested 
empirically, but 50µl is a good start) 
• incubate at 370C for 20 minutes 
• add ammonium sulphate to a final concentration of 0.25M to the solution (e.g. 
12.5 µl from a 1M stock into 50 µl) 
• leave on ice for 5 minutes 
• spin down at 5000g for 3 minutes 
• keep supernatant (corresponds to the chromatin fraction) to be loaded onto the gel 
later  
• resuspend pellet in CSK buffer containing 2M NaCl (volume to be added should 
be tested empirically, but 50µl is a good start) 
• leave on ice for 5 minutes 
• spin down at 5000g for 3 minutes 
• keep supernatant (corresponds to the washing fraction) to load onto the gel later 
• resuspend pellet in 8M urea to solubilize the nuclear matrix fraction (again, the 
volume to be added depends on how concentrated your protein of interest will be 
in this fraction). 
• load an equivalent amount of protein determined by Bradford assay of each 
sample fraction and check where your protein of interest co-fractionates by SDS-
PAGE and Western blotting. 
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Cytoskeletal Buffer 
Aliquots stored at -200C: 
10mM PIPES pH 6.8, 300mM sucrose, 100mM NaCl, 3mM MgCl2, 1mM EGTA 
 
To be added just prior to use:       
leupeptin, aprotinin and pepstatin (1µg/ml each), 1mM PMSF, 1mM DTT, 0.5% 
Triton X-100 
 
II.27 BrdU incorporation assay 
The methodology described in Lebrin et al. was followed (Lebrin et al., 2001). BrdU 
is an analogue of thymidine, allowing the detection of DNA synthesis in proliferating 
cells. Added to the media, cells incorporate BrdU in place of thymidine during DNA 
synthesis (S-phase of the cell cycle). Cells that could be visualized as positive for both 
β-galactosidase (β-gal; used as internal control for transfected cells) and BrdU were 
counted as positive for BrdU incorporation. BrdU and β-gal positive cells were 
detected by indirect immunofluorescence using a Zeiss Axiophot microscope (Carl 
Zeiss Ltd.) connected to a 3CCD camera (Sony). Per slide, at least 100 β-gal positive 
cells in five different fields were counted and each β-gal positive cell was checked for 
having or not incorporated BrdU. 
• plate CEF/U2OS cells onto (35/10mm) immunofluorescence dishes in DMEM 
10% FCS 
•  at a confluency of approximately 50%, co-transfect cells with β-gal plus IDten-1 
or with β-gal plus empty vector pCEP-pu 
• add BrdU to a final concentration of 20µM into the media and incubate cells for a 
further 17 +/- 3 h or until 80% confluency 
• fix cells in 3.7% paraformaldehyde for > 20 minutes at RT 
• rinse once with PBS- 
• treat cells with 2N HCl for 30 minutes at RT to render the chromatin accessible 
• wash 5x with PBS- 
• block unspecific sites with 3% BSA in PBS- for 1h at RT 
• incubate primary antibodies (anti-β-gal 1:500, anti-BrdU 1:500), overnight at 40C 
• wash 3x with PBS-T (10 minutes each)   
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• incubate secondary antibodies (goat anti-rabbit FITC conjugated, goat anti-mouse 
rhodamine conjugated at 1:1000) and DAPI (1:200) for 1h in the dark 
• wash as above and mount coverslips with moviol 
• keep slides in the dark until visualization 
 
II.28 Glutathione assay 
The methodology described in the Manufactorer's instruction was followed 
(ApoAlertTM Glutathione Detection Kit - Clontech). The concept behind this method 
as specified by Clontech is that in healthy cells, glutathione acts as a redox buffer. 
However, in Jurkat and some other cell types, the plasma membrane contains an ATP-
dependent glutathione (GSH) transport system that is triggered by the initiation of 
apoptosis. When GSH is actively pumped out of the cell, the cytosol is shifted from a 
reducing to an oxidizing environment (Wang et al., 2000). An overview of the 
experimental set up is presented below: 
 
 
(n=2)
Wt+ 
1uM
Wt+ 
10uM K3-
K3+
1uM
K3+
10uM
D3- A1-
D3+
1uM
D3+
10uM
A1+
1uM
A1+
10uM
4. centrifuge at 700xg for 5 min at 4C & lyse cells in ice-cold cell lysis buffer 100ul 
7. measure fluorescence in a fluorometer λ=395/480nm
Wt-
2. 24 hrs after induction: collect cells by scraping
3. centrifuge at 700xg & resuspend pellet in 1ml ice-cold cell wash buffer
GSH Assay
1. Cells were induced (+) or not (-) with 1 and  10uM ponasterone
5. incubate 10 min on ice, then centrifuge at maximum speed for 10 min
6. to the supernatant, add 100 mM MCB and incubate samples at 37C for 30 min
(the level of fluorescence represents the abundance of glutathione in the cytosol)  
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II.29 Nuclear and cytoplasmic extraction of proteins 
The protocol by Timchenko et al. was followed (Timchenko et al., 1997). In order to 
enrich for nuclear and cytoplasmic proteins, chicken tissues were disrupted on ice 
with buffer A in a dounce homogeniser with 15 to 20 strokes using a tight pestle. 
Tissue debris was collected by centrifugation at 5000rpm at 040C for 10 minutes. The 
pellet was washed once in buffer A and the supernatant was frozen as the cytoplasmic 
fraction. Nuclei were then incubated in buffer B on ice for 30 minutes, and 
centrifuged as before to separate the supernatant containing the nuclear extract from 
the nuclear pellet containing the nuclear matrix.  
Buffer A: 25mM Tris HCl pH 7.5, 50mM KCl, 2mM MgCl2, 1mM EDTA and 5mM 
DTT 
Buffer B: 25mM Tris HCl pH 7.5, 0.42M NaCl, 15mM MgCl2, 0.5mM EDTA, 1mM 
DTT and 25% sucrose 
note: add protease inhibitor cocktail (Roche) in all buffers 
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III. RESULTS 
PART 1. The intracellular domain of teneurin-1 interacts with MBD1 and 
CAP/ponsin resulting in subcellular codistribution and translocation to the 
nuclear matrix 
Samantha M. Nunes, Jacqueline Ferralli, Karen Choi, Marianne Brown-Luedi, 
Ariane D. Minet and Ruth Chiquet-Ehrismann 
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Supplementary data not shown in the publication:  
To corroborate the finding of the CEF nuclear staining we decided to 
look for the presence of the cleaved endogenous teneurin-1 in the nuclear 
matrix of chicken cells by immunocytochemistry. Antibody against the N-
terminus of teneurin-1 "anti-N" was able to reveal the same staining pattern 
regardless if cells were treated or not to uncover their nuclear matrix 
(supplementary figure 1).  
Subsequently, Western blotting of nuclear matrix fractions of CEF cells 
was used to confirm the presence of the putative endogenous teneurin-1 not 
only in cultured chicken cells (supplementary figure 2B), but also in chicken 
tissues. Nuclear matrix fractions derived from total brain lysates, revealed the 
presence of a 75kDa band, at much weaker levels, also the 55kDa band with 
the "anti-N" antibody, in contrast to the nuclear matrix fractions of heart and 
lung, where no teneurin-1 could be detected (supplementary figure 2A). 
Finally, clones induced to express full-length teneurin-1 (EcR-FLten-1) 
or HEK-293 cells transiently transfected with FLten-1 were extracted and 
assayed by Western blotting using the "anti-N" antibody. Noteworthy, in both 
cell lines, a similar pattern of teneurin-1 cleavage was observed, including the 
teneurin-1 fragments of 55kDa and 75kDa (supplementary figure 3).  
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Supplementary Figure 1. Indirect immunofluorescence of teneurin-1. Staining 
using the "anti-N" antibody in CEF cells untreated (A) or treated (C) to uncover their 
nuclear matrix revels a nuclear signal. (B) Untreated cells stained with pre-immune 
serum are shown as control. Pictures were taken at 100x magnification. 
 
 
 
 
 
 
 
Supplementary Figure 2. Endogenous teneurin-1 in chicken tissue and chicken 
cells. Immunoblots of the nuclear matrix fraction of chicken brain, heart and lung 
lysates (A) and from the nuclear matrix fraction of CEF cells (B). Both in brain and in 
CEF lysates, bands of similar molecular weight were detected that may correspond to 
endogenous teneurin-1. 
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Supplementary Figure 3: Cleavage of transiently transfected full-length 
teneurin-1 in HEK-293 cells. HEK-293 cells were transiently transfected with a 
vector encoding the full-length teneurin-1 (FLten-1). CEF cells were transfected with 
IDten-1 and stable clones were induced to express full-length teneurin-1 (EcR-FLten-
1). Extracts were probed in Western blotting with anti-N antibody. Star represents the 
position of full-length teneurin-1. The arrow represents the 55kDa band and other 
cleaved fragments are seen. 
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Part 2. Investigation of teneurin-1 signalling 
Samantha M. Nunes, Karen Choi and Ruth-Chiquet Ehrismann 
 
Based on studies in Drosophila, where ten-m1 was found to be secreted 
and mutants displayed segmentation defects typical of mutations in pair-rule 
genes, the hypothesis emerged that teneurins may be proteolytically cleaved in 
a Notch-like fashion after being synthesized as a membrane-bound 
transcription factor. In a first step, the protein would be cleaved extracellularly 
as shown for teneurin-2 (Rubin et al., 1999). An additional cleavage still to be 
characterized would then release the intracellular domain that is thought to 
translocate to the nucleus and affect gene expression as shown for teneurin-2 
(Bagutti et al., 2003). 
Since the cleavage mechanism of teneurin-1 full-length protein has not 
yet been elucidated, I decided to generate stable clones of different forms of the 
protein for studies in cell culture. EcR-IDten-1, EcR-MLten-1 and EcR-FLten-
1 expression was driven by a promoter that responded to an activated ecdysone 
hormone receptor. This allowed the expression of these different forms of 
teneurin-1 at lower and closer to physiological levels than the use of the strong 
CMV-promoter-driven expression of IDten-1 in pCEP-Pu that also mimics the 
putative cleavage product of the full-length protein. Importantly, this system 
also allowed teneurin-1 gene expression to be switched on and off when 
required.  
Some of the experiments with these constructs are described in the 
publication of Part 1 of the Results section. Additional experiments that did not 
fit in that context are described below. Although at present not mature enough 
for submission to a peer-reviewed journal, these experiments will serve as a 
basis for follow-up studies.   
 
III. 1 Immunoprecipitation of the endogenous teneurin-1 
In a first step trying to understand the cleavage of teneurin-1, we 
attempted to detect the endogenous form of the protein. Preliminary Northern 
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blot analyses of teneurin-1 in chicken had revealed that at the developmental 
stages tested, expression in the brain starts at E5, gradually increases to a 
higher level by E11 and reaches its plateau at E17. The adult brain also shows 
expression of teneurin-1, which is not the case for other adult organs such as 
liver and lung (Minet et al., 1999). 
For immunoprecipitation, brain, heart and lung from chicken embryos 
(E11) were used as sources of positive and negative controls respectively for 
the presence or absence of endogenous teneurin-1 protein. Tissues were 
homogenized in RIPA buffer and the equivalent of 500µg of total protein was 
processed for immunoprecipitation with "anti-N" antibody followed by 
Western blot detection of precipitated bands. In agreement with the above-
mentioned report (Minet et al., 1999), a 75kDa protein band was 
immunoprecipitated only from brain tissue (figure 1A). Interestingly, the 
presence of a 75kDa protein has been observed previously in immunoblots of 
nuclear matrices of CEF cells and of chicken brain tissue (cf. supplementary 
figure 2). Moreover, using a different polyclonal antibody directed against the 
N-terminus of teneurin-1 called "anti-A" for precipitation, the same protein 
band was detected by the "anti-N" antibody on Western blots (figure 1B). As 
control for both immunoprecipitations, pre-immune serum was added to the 
protein lysate instead of the anti N-terminus antibodies and processed in the 
same way. In addition, Western blotting using an antibody against the "C-
terminus" of teneurin-1 "anti-C" revealed no signal, indicating that the 
immunoprecipitated protein was not the full-length protein, but a processed 
form instead (not shown). 
Apart from chicken tissues, it was tested whether teneurin-1 could be 
immunoprecipated from the cortex of mice using the chicken "anti-N" 
antibody. Although teneurin-1 shows high homology between these two 
species, the chicken antibody did not seem to be able to immunoprecipitate the 
mouse teneurin-1 protein (not shown). However, on Western blots of total 
lysate of cortex a 75kDa protein band was detected, which was different from 
the 80kDa band in total lysate of heart particularly prominent in the blot with 
Samantha Michele Nunes Radimerski 85
Results - Part 2 
the "anti-A" antibody (figure 2). At present it cannot be distinguished whether 
this 80kDa band represents a distinct proteolytic fragment of teneurin-1 present 
in heart or crossreactivity with an unrelated protein expressed in that tissue. 
The detection of a 75 kDa band in chicken brain lysates (as well as possibly in 
mouse brain) suggests that teneurin-1 may undergo constitutive cleavage in the 
extracellular domain in vivo. 
 
III.2 Effects of IDten-1 overexpression on the rate of cell proliferation 
 
I noticed that cell lines expressing IDten-1 seeded at the same density as 
control cells without IDten-1 expression displayed a lower cell number after 
several days in culture. Therefore, it was postulated that this effect might be 
due to a decrease in proliferation and an increase in differentiation in the 
presence of IDten-1. To exclude that the phenomenon was due to increased 
apoptosis, advantage was taken of an in vitro assay that monitors the cellular 
redox status. In this assay cytosolic glutathione (GSH) levels, which are 
reduced in cells that are in early stages of apoptosis are measured (Wang et al., 
2000). Stable clones of EcR-IDten-1 (D3 and A1), EcR-IDten-2 (K3) and Wt 
293-EcR cells were seeded in 6-well dishes and after 12 hours, IDten-1 protein 
expression was induced in half of the wells with ponasterone. 12 hours later, 
monochlorobimane (MCB) was added to the medium and its incorporation into 
cellular cytosolic glutathione was measured using a fluorometer. No significant 
differences in GSH levels were detected between induced and non-induced 
cells (figure 3). This suggested that expression of IDten-1 was unlikely to have 
an impact on the growth rate of cells by inducing global changes in their redox 
status and programmed cell death.   
To quantify a possible reduction in the proliferation rate after induction 
of IDten-1 expression, the number of cells in S-phase of the cell cycle was 
monitored using a BrdU incorporation assay. To do this, beta-galactosidase 
(βgal) was co-transfected either with the IDten-1 construct or with the empty 
pCEP-vector to compare BrdU incorporation of the transfected cells. Indeed, 
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overexpression of IDten-1 in U2OS cells caused a reduction of approximately 
30-40% in BrdU and βgal-positive cells as compared to vector transfected cells 
indicating that the presence of this domain is capable of reducing the capacity 
of cells to proliferate at their normal rate. Similar results were obtained when 
BrdU incorporation was assessed in primary chick embryo fibroblasts (CEF) 
cultures transfected to express IDten-1 (figure 4). Therefore, it can be 
speculated that the nuclear form of IDten-1 facilitates the transition from cell 
proliferation to cell differentiation (see discussion).  
 
III.3 Analyses of the involvement of IDten-1 in signal transduction 
Since cells expressing IDten-1 displayed a reduced rate of proliferation 
as measured by BrdU incorporation assays, it was investigated whether this 
correlated with the level of expression and activity of selected cell cycle 
regulators involved in proliferation. A first candidate that was checked was the 
p53 tumour suppressor protein, which is known to have a direct role in the 
control of cell proliferation (Komarova et al., 1997). As an indirect readout of 
cellular p53 activity, advantage was taken of a p53-responsive luciferase 
reporter system (see details in Material and Methods). Figure 5 shows the 
relative luciferase values corresponding to p53 activation of overexpressed 
IDten-1 in both U2OS cells (a,b) and in primary CEF cells (c,d). Considering 
the experimental variations (see error bars), only a subtle reduction in p53 
activity was detected in cells transfected with the IDten-1 as compared to the 
cells transfected with the vector alone.  
Western blotting using anti-p53 phospho-Ser392 antibodies in EcR-cells 
induced to express IDten-1 revealed that phosphorylation at this site of p53 
remained unaltered (figure 6). However, that does not exclude that other sites 
known to be phosphorylated in p53 (e.g. serine 6, 9, 15 and 20) could be 
affected. Finally, the effects of IDten-1 on other signalling pathways known to 
control cell proliferation were investigated. The phosphorylation status of 
p44/p42 MAPK and PKB were analysed by Western blotting and neither 
activity was altered in cells expressing IDten-1. Thus, further experiments are 
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required to shed light onto the factors and pathways that are induced and may 
affect the rate of proliferation in response to the expression of IDten-1 (see 
discussion). 
 
III.4 Microarray Analysis of the Intracellular Domain of teneurin-1   
(IDten-1) expressing cells 
Microarray analysis was performed to investigate the possible roles of 
the IDten-1 domain in gene regulation and to identify its potential target genes. 
The experiment consisted of a time course of 0, 6, 12 and 24 hours after 
induction of IDten-1 expression with ponasterone. Since the induction of 
IDten-1 relied on the addition of ponasterone, one concern was that the non-
physiological effects of this drug or the activation of the ponasterone receptor 
could trigger the changes in gene expression independently of IDten-1 
expression. To address this point, wild type EcR-293 cells were transfected 
with the empty vector pIND to generate the stable EcR-pIND "empty vector" 
control cells. These cells allow the identification of possible effects resulting 
from the addition of ponasterone to the medium. 
In the microarray experiment, EcR-IDten-1 samples were compared 
with control EcR-pIND samples as a screen for differentially expressed genes. 
Figure 7 shows the accumulation of IDten-1 protein after the induction of its 
expression in the stable EcR-cell line C6 at the times indicated. N-terminal 
anti-teneurin-1 antibody "anti-N" detected a band by Western blotting that 
migrated at the expected molecular weight (55kDa). Similar results were 
obtained with other stable cell lines (cf. figure 16). Furthermore, 
immunofluorescence using "anti-N" showed that IDten-1, but not MLten-1, 
was predominantly localised to the nucleus of EcR cells following induction by 
ponasterone (figure 8). In parallel samples, total mRNA was extracted from 
these cells at the time points shown in figure 7 for the microarray analysis. 
Probes were prepared and Affymetrix U133A GeneChipsTM were hybridised by 
the FMI microarray facility. After pre-filtering the data (see details in Materials 
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and Methods), the following analysis was performed on these data with the 
assistance of Edward Oakeley:  
 
1-Way ANOVA analysis 
In addition to following the fold change of genes, we wanted to be sure 
that changes observed were robust and reproducible. The fold change lists were 
then combined and a 1-Way analysis of variance (ANOVA) test was performed 
(see details in Materials and Methods II.14). 263 genes passed this test and 
were therefore differentially expressed between the control and the treated 
samples (figure 9). The Affymetrix annotations of these 263 genes are shown 
in the appendix supplied at the end of this thesis. This set of genes was 
classified using the following website (http://fatigo.bioinfo.cnio.es/) - see 
details in Material and Methods II.14. The chart presented in figure 10 lists the 
percentage of genes attributed to a certain Gene Ontology function. It shows 
that the largest group of genes that change their expression levels are within the 
group of genes classified as nucleic acid binding.  
 
2-Way ANOVA test 
In order to refine the analysis, a 2-Way ANOVA test was performed, 
which allowed testing the interaction of two parameters at a significance level. 
The 2-Way ANOVA tested the interaction of time and treatment with 
ponasterone (see details in Materials and Methods II.14). This test reduced the 
original list to a total of 39 genes. A list containing the Affymetrix annotations 
is provided in the appendix of this thesis. The expression kinetics of these 39 
transcripts as well as their classification using “Fatigo” 
(http://fatigo.bioinfo.cnio.es/) is shown in figures 11 and 12. Interestingly, 
nucleic acid binding genes and transcription factor activity genes are now 
representing over half of all genes identified (figure 12). Ideally, an IDten-1 
target gene would remain unaltered in the control pIND sample and respond by 
either being up - or downregulated in the presence of IDten-1. Strikingly, the 
expression values for the AB033066 gene shown in figure 13 precisely 
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matched these criteria and this gene was therefore chosen for further 
investigation.  
 
III.5 Identification and characterization of a gene induced by IDten-1  
The 3'UTR sequence of the AB033066 gene was used for a blast search 
against the NCBI database from PubMed to find a full-length cDNA and the 
corresponding protein. It was possible to obtain an alignment of known EST's 
as well as cDNAs covering the entire coding region that support the existence 
of the AB033066 gene transcript. Furthermore, the program also predicted that 
two consecutive transcripts (AB033066/AK125718 and AK094821) might be 
joined together to form a single longer transcript called XM_039676 (figure 
14). To test this prediction, RT-PCRs were performed using primers derived 
from transcript AK094821 and transcript AK125718 indicated in figure 14. A 
single band of approximately 1100bp spanning the two transcripts could be 
amplified (figure 15A), confirming the computer-based prediction that these 
transcripts are part of one single gene. From now on, this gene will be called 
XM_039676. 
To confirm the results of the microarray analysis Reverse Transcription 
RT-PCR was performed on mRNA isolated from the same EcR-IDten-1 clone 
C6. As shown in figure 15 B, in the presence of IDten-1 the expression levels 
of the XM_039676 transcript are strongly induced whereas tubulin, which was 
selected as internal control based on its unaltered expression profile throughout 
the experiment, remains unaffected. To exclude that induction of XM_039676 
is a cell clone specific phenomenon, mRNA from two other clones that can be 
induced to express IDten-1 B2 and C13 was extracted, reverse transcribed and 
RT-PCR was performed as described above. The results of this analysis are 
shown in figure 16. All clones expressing IDten-1 also contain elevated levels 
of XM_039676 transcripts. Therefore, induction of XM_039676 consistently 
correlates with IDten-1 expression and remains an interesting candidate as a 
teneurin-1 target gene. 
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No experimental data or publications are available about this protein or 
gene. To explore possible functions of this newly identified putative IDten-1 
target gene, the Scansite database (http://scansite.mit.edu/) was used to check if 
the XM_039676 gene product could reveal any conserved protein domains that 
would hint at its function. An ATPase/AAA and a BROMO domain were 
predicted to be present in the KIAA1240 protein. The entire protein is supposed 
to be encoded by 35 exons giving rise to a protein with a calculated molecular 
weight of about 161 kDa (figure 17).  
 
III.6 Promoter identification 
In order to test whether XM_039676 is directly controlled by IDten-1 
we tried to identify the promoter sequence to generate a reporter system (e.g. 
luciferase) for measuring the activation of XM_039676 by teneurin-1.  
To identify the promoter, an 8 kb sequence upstream of and including 
the beginning of the putative first exon of XM_039676 was selected and 
blasted against the mouse genome with the expectation to find similar 
regulatory DNA sequences and/or exons between these two species. This 
search revealed two highly homologous sequences present in the mouse 
genome corresponding to the predicted first exon plus an additional 150 bp 
sequence about 4 kb upstream (figure 18). Such a high degree of homology 
suggested that the latter might represent an additional exon. We therefore 
postulate that the promoter of the XM_039676 gene might be located 5' to 
either of these putative first exons. The cloning of the two potential promoter 
regions in front of a luciferase gene will allow the generation of a reporter 
system for use in future experiments where activation by IDten-1 can be 
experimentally tested.  
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III.7 Figures 
 
 
 
 
Figure 1. Immunoprecipitation of teneurin-1 from chicken tissues. (A) 
Immunoprecipitation followed by Western blotting with "anti-N" antibody detects a 
protein with apparent molecular weight of 75kDa from chicken brain extracts. (B) 
Immunoprecipitation using another antibody against the N-terminus "anti-A" 
followed by detection with "anti-N" recognizes the same protein band. IP: immuno-
precipitation, PIS: pre-immune serum. 
 
 
 
 
 
Figure 2. Endogenous teneurin-1 in mouse tissues. Immunoblots of mouse heart 
and cortex analysed by both antibodies against the N-terminus of the chicken 
teneurin-1 "anti-A" and "anti-B". These antibodies are able to recognize the 75kDa 
protein band in the cortex. In the heart, an 80kDa signal is detected. Pre-immune 
serum (PIS) was used as control. 
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Figure 3. Determination of GSH levels in stable clones expressing IDten-1 and 
IDten-2. Arbitrary fluorescence readings representing the GSH levels in stable IDten-
1 (D3,A1), IDten-2 (K3) and wild type cells with and without addition of different 
concentrations of ponasterone. Error bars represent the standard deviations of 
replicates. 
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Figure 4. Measurement of the rate of cell proliferation in IDten-1 overexpressing 
cells. Comparison of levels of BrdU incorporation in U2OS and CEF cells transfected 
either with empty vector control or with IDten-1. IDten-1 transfected cells show a 
reduction in proliferation rates seen by fewer BrdU-positive cells as compared to 
control cells. Results are derived from five independent experiments in which three of 
them were performed in U2OS cells and two performed in CEF cells. Error bars 
represent the standard deviations of replicates. 
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Figure 5. Determination of p53 activity in IDten-1 overexpressing cells by 
luciferase assay. Results are derived from four independent experiments, each done 
in duplicate. The first two were performed in U2OS cells (a, b) and the last two in 
primary CEF cells (c, d). Subtle changes in p53 activation could be detected when 
U2OS and CEF cells were transfected with empty vector as control and compared 
with cells transfected with IDten-1. Considering the experimental variations these 
changes are not significant. 
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Figure 6. Effects of IDten-1 overexpression on phosphorylation of MAPK, p53 
and PKB. Ponasterone was added over a time course of 48 hours to EcR-IDten-1 
cells and extracts were prepared at the indicated times. Induction of IDten-1 protein 
and levels of phosphorylated p44/p42, p53 and PKB were assessed by immunoblot.  
 
 
 
 
 
 
Figure 7. Time course of IDten-1 induction in cells used for microarray analysis. 
Extracts were prepared at the indicated times from empty vector control cells (EcR-
pIND) and IDten-1 C6 cells induced with ponasterone and probed for IDten-1 
expression by Western blotting. mRNA from each clone was isolated at the defined 
time points and used for microarray analysis. Note that empty vector control cells are 
negative for IDten-1 expression. 
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Figure 8. Immunofluorescence of stable clones induced to express teneurin-1. 
Staining by indirect immunofluorescence using "anti-N" antibodies reveals that IDten-
1 expression is predominantly nuclear (upper panels) whereas pre-immune serum 
(PIS) gives no staining. MLten-1 expression results in a nuclear excluded pattern 
(lower panels). 
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Figure 9. Expression kinetics of genes affected by the expression of IDten-1. The 
graphics depicts the expression kinetics of the 263 genes that passed a 1-Way 
ANOVA test over a 24-hour time course. Colour information is based on the time 
point ID 24h. 
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Figure 10. Classification of the 263 genes after analysis with FatiGO. FatiGO: a web tool 
for finding significant associations of Gene Ontology terms with groups of genes. 
Bioinformatics 2004 20: 578-580 
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Figure 11. Expression kinetics of genes affected by the expression of IDten-1. The 
expression kinetics of the 39 genes that passed a 2-Way ANOVA test over a 24-hour 
time course is shown. Colour information is based on the time point ID 24h. 
 
 
 
 
 
 
 
Figure 12. Classification of the 39 genes after analysis with FatiGO. FatiGO: a web tool 
for finding significant associations of Gene Ontology terms with groups of genes. 
Bioinformatics 2004 20: 578-580 
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Figure 13. Expression kinetics of the AB03066 gene affected by the expression of 
IDten-1. The expression of this gene is induced by IDten-1 over a 24-hour time 
course and remains expressed at a low level in EcR-pIND control cells.  
 
 
 
 
 
 
Figure 14. Known ESTs and cDNAs covering the entire coding region of the 
AB033066 transcript. PubMed predicts that the two consecutive transcripts 
(AB033066/AK125718 and AK094821) are joined together to form a single longer 
transcript XM_039676 depicted in red as M. Each spike corresponds to an exon. 
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Figure 15. PCR analysis of the XM_039676 gene and of the induction of the 
transcript induced by IDten-1. (A) PCR reactions were performed with the primers 
indicated in figure 14 and confirmed that the AB033066 and the AK094821 genes are 
joined together forming a longer transcript (XM_039676). (B) RT-PCR of mRNA 
isolated from EcR cells induced to express IDten-1 for 24 hours shows the induction 
of the XM_039676 gene whereas the expression level of the AB033066 gene in vector 
control cells is very low. Tubulin, which was used as internal control, remains 
unaltered. 
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Figure 16. Analysis of the induction of the XM_039676 transcript in other clones 
induced to express IDten-1. Clones B2, C13 and C6 have been induced to express 
IDten-1 for 24 hours. IDten-1 can be detected by Western blots of cell extracts, except 
for the vector control cells (bottom panel). The RT-PCR analysis shows that all clones 
express similar amounts of tubulin transcripts (top panel) whereas XM_039676 
transcripts are highly expressed in clones induced to express IDten-1 as compared to 
the vector alone (middle panel). The primers used to assess the induction of 
XM_039676 transcripts amplify the region spanning exons 34-35.  
 
 
 
 
 
 
 
 
 
Figure 17. Domain structure of the KIAA1240 protein. The XM_039676 gene 
contains 35 exons. The predicted molecular weight of the protein encoded by the 
XM_039676 gene is 161kDa. The protein harbours a central AAA ATPase domain 
and a Bromodomain.   
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Figure 18. Schematic representation of the putative promoter region of the 
XM_039676 gene. (A) Gene prediction of XM_039676. (B) An 8 kb region upstream 
and including the first putative exon of the XM_039676 gene was used for the blast 
search against the mouse genome. (C) This search revealed two highly homologous 
regions of about 200bp each (red bars underlined). The one on the right corresponds 
to the first exon, whereas the one 4kb upstream may indicate the presence of yet 
another exon containing 5'UTR sequences of the XM_039676 transcript. 
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IV. DISCUSSION 
Recently, the newly described mechanism defined as Regulated 
Intramembrane Proteolysis (RIP) has been implicated in the processing of 
transmembrane proteins. Such a mechanism is also envisaged for the teneurins. 
It would allow for example, neurons expressing the cell-anchored teneurin, to 
deliver a signal to the nucleus and counteract the proliferating program of cells 
and/or promote differentiation. The postulation that teneurin-2 promotes 
differentiation is based on the fact that in brain its transcripts could not be 
detected in the cell dense ventricular zone. That suggested that teneurin-2 was 
not expressed by neuroblasts, but by postmitotic neurons about to establish new 
connections (Rubin et al., 1999). 
Interestingly, cells overexpressing IDten-1 show a reduced rate in 
proliferation as measured by BrdU incorporation assays. If one considers 
similar nuclear functions for both teneurin proteins, it can be speculated that 
this result is due to a modulation of gene expression in order to facilitate a 
transition from a proliferating state to a differentiating one.  
During development, teneurin was found to play a crucial role in the 
determination of the Drosophila segmental body pattern. Genetic analysis has 
revealed that the ten-m/odz gene belongs to the pair-rule class of transcription 
factors based on the mutant phenotype observed. In addition, ten-m/odz was 
shown to cooperate with opa in the same signalling cascade (Baumgartner et 
al., 1994). Zic genes are the vertebrate homologues of opa. In a recent study of 
molecular mechanisms of retinal axon guidance, disruption of gradient 
expression of Zic3 resulted in abnormal intraretinal axon projection (Zhang et 
al., 2004). Since in the Drosophila work the authors have postulated that ten-m 
may influence the activity of opa (Baumgartner et al., 1994) and later on 
teneurin-2 was shown to repress zic-1-mediated transcription (Bagutti et al., 
2003), it is possible that a functional interaction of zic proteins with the 
teneurin family members exists in vivo. 
The strategies used to investigate the synthesis and processing of 
teneurin-1 and the involvement of its intracellular domain in gene regulation 
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were the following: (1) generation of antibodies to detect endogenous and 
different forms of overexpressed teneurin-1 in cell culture; (2) yeast two-hybrid 
screen to identify interacting proteins of IDten-1 and (3) microarray analysis to 
identify possible target genes of IDten-1. The results of the three approaches 
described in this thesis will the basis for the following discussion, including an 
extension of the discussion already provided in the published Part 1 of the 
Results section (Nunes et al., 2005).  
 
Strategy 1. Generation of antibodies and overexpression of different forms 
of teneurin-1 in cell culture 
Antibodies against teneurin-1 were raised to have a tool for cytological 
staining and biochemical analyses. The use of specific antibodies was useful to 
reveal the subcellular localisation of various forms of the protein and their 
expression pattern in overexpression experiments, including the one of the 
constructs encoding the intracellular domain of teneurin-1 that mimic cleavage 
of the endogenous protein.  
Interestingly, the pattern of overexpressed IDten-1 protein was highly 
similar to that of overexpressed IDten-2 in cells. Despite the accumulation of 
both proteins in subnuclear domains, the teneurin-2 intracellular domain 
frequently co-stained with PML bodies (Bagutti et al., 2003), while this was 
only occasionally the case for IDten-1. Overexpressed IDten-1 protein was 
found to be present in a special subnuclear structure thought to be involved in 
processes such as DNA replication, transcription and mRNA splicing, the 
nuclear matrix (Nunes et al., 2005). It would be of interest to investigate 
whether IDten-2 also cofractionates in the nuclear matrix and whether any 
correlation can be made between the presence of these proteins in the nuclear 
matrix and colocalisation with PML bodies. Alternatively, does interaction with 
different protein partners as shown in (Nunes et al., 2005) play a role in 
targeting members of the teneurin family to distinct subnuclear structures? 
Despite the high degree of similarity between teneurin-1 and -2, the two 
proteins are expressed in a specific subset of neurons of different but 
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interconnected sites of the developing chicken brain (Rubin et al., 2002). 
Therefore, it could well be that despite the nuclear localisation of both proteins 
the interaction with particular subnuclear structures (e.g. nuclear matrix) is 
mutually exclusive, and in turn responsible for mediating independent 
functions.  
In order to gain a better understanding of IDten-1 signalling, it could be 
investigated if an association with the nuclear matrix occurs as a consequence 
of specific signals as described for PCNA. PCNA translocates to the nuclear 
matrix in mid-G1 and (from the nuclear matrix) to chromatin when DNA 
replication starts (Naryzhny and Lee, 2004). This could be achieved by staining 
of synchronized IDten-1 expressing cells at different stages of the cell cycle. 
In this context, it would be compelling to check whether the reduced rate 
in proliferation of cells overexpressing IDten-1 is linked to association of 
IDten-1 with the nuclear matrix as opposed to direct effects on the activities of 
specific signalling pathways. For example, it would be possible to measure the 
proliferation rate of cells expressing IDten-1 mutated at sites containing 
putative nuclear matrix association signal(s)/or nuclear localisation signal(s). 
The possibility that both mechanisms of action might be integrated 
would be even more exciting. For example, triggering of a specific signalling 
pathway by IDten-1 promotes its shuttling to the nuclear matrix and as a result 
of this event cell cycle progression is delayed. Some interesting candidate 
pathways that could be affected by IDten-1 such as MAPK, PKB and p53 
activation were investigated. However, no changes based on the presence of 
IDten-1 could be detected. In the case of p53, one limitation encountered was 
the fact that its activation was checked in an indirect way. Instead of a reporter 
assay, in the future one could analyse the expression of p53 target genes 
previously shown to be involved in slowing cell cycle progression e.g. p21.  
The experiments done with the anti-teneurin-1 antibodies provided some 
evidence of an extracellular and intramembrane cleavage of teneurin-1 and its 
translocation to the nucleus. 
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(A) By Western blotting, detection of the induced form of the full-length 
teneurin-1 protein was accompanied by additional smaller fragments when anti-
N terminus antibody and not anti-C antibody was used. The same smaller 
fragments could be detected with the antibody against the Flag-tag of the 
protein, corroborating the hypothesis that these fragments are cleaved forms 
containing the N-terminus of teneurin-1. In sub-fractionation experiments, both 
the soluble fraction and the insoluble nuclear matrix of cells were positive for 
IDten-1 expression. However, only the nuclear matrix fraction of cells induced 
to express the full-length teneurin-1 and not the one of un-induced cells 
revealed the presence of an exclusive band, which ran at the same size as the 
putative intracellular domain (Nunes et al., 2005). 
(B) Based on the pattern of expression of the overexpressed protein, we 
attempted to stain endogenous teneurin-1 by immunofluorescence of chicken 
embryo fibroblasts. In agreement with the overexpression studies, IDten-1 not 
only localised to the nucleus (Nunes et al., 2005), but its staining was also 
positive in the nuclear matrix of these cells. 
  (C) Using two different polyclonal antibodies against the same N-
terminal region of the protein, immunoprecipitation experiments followed by 
Western blotting revealed the presence of a 75kDa band in lysates of chicken 
brain. No immunoprecipitated band could be detected in liver, in agreement 
with the absence of the teneurin-1 mRNA in this organ (Minet et al., 1999). 
Although speculative, a few explanations are possible.  
First, the immunoprecipitated band could correspond to a cleaved form 
of the protein, which would still be membrane bound. This is supported by the 
absence of a signal when an anti "C" antibody against the C-terminus of the 
protein was used, indicating that this part of the protein was not precipitated. 
Although teneurin-1 does not seem to possess a perfect furin consensus site like 
teneurin-2 (Rubin et al., 1999) and Notch (Logeat et al., 1998) the possibility 
remains that related proteases are involved in similar cleavage mechanisms of 
teneurin-1.   
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Interestingly, a S1P site (RXX/L/K) (Espenshade et al., 1999) present in 
the teneurin-1 sequence (at amino acid position 746 - RCTL, (highlighted in 
red in figure 19) could generate a fragment with a molecular weight of 
approximately 80kDa. In this case, however, in contradiction to what has been 
shown to be a prerequisite for a secondary intramembrane cleavage, the 
extracytosolic portion remaining would be much longer than the 30 amino 
acids described in a previous report (Brown et al., 2000). On the other hand, 
considering that teneurins might be cleaved in a constitutive manner similar to 
Notch, the fragment of 75kDa might represent a constitutively cleaved chain 
that participates in forming the intact molecule. Dibasic sites have been 
observed frequently as recognition sites for a family of mammalian proteases 
with similarity to bacterial subtisilin (Barr et al., 1991). All mouse ten-m 
proteins contain several dibasic sites close to the membrane-spanning region 
and one of them is conserved in all sequences and in the Drosophila ten-m/odz 
and ten-a. Dibasic sites can also be found in the chicken teneurin-1 sequence 
(figure 19). Another indication for extracellular cleavage of teneurins comes 
from the following publication. Schaefer et al. have detected a soluble form of 
γ-heregulin in the supernatant of the breast cancer cell line MDA-MB-175, 
suggesting proteolytic processing of this protein (Schaefer et al., 1997). In this 
cell line, the γ-heregulin gene has been found rearranged and fused with the 
DOC4 (rat teneurin-4) gene (Wang et al., 1999). The resulting ten-m4 γ-
heregulin fusion protein includes the dibasic site sequence juxtaposed to the 
transmembrane domain. Therefore, the potential for shedding of the 
extracellular domain may be a characteristic of all ten-m family members 
(Oohashi et al., 1999). In other words, besides teneurin-2 (which has been 
shown to be processed at a furin site) the activity of other teneurins and related 
proteins might also be subject to proteolytic cleavage (Rubin et al., 1999). 
The second explanation is based on the in-vitro sub-fractionation 
experiment of transfected U2OS and EcR-IDten-1 expressing cells (discussed 
in (A)), where IDten-1 was found associated with the insoluble nuclear matrix 
fraction of these cells. Assuming that the same occurs in vivo, it is conceivable 
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that the nuclear matrix associated part of the protein cannot be 
immunoprecipitated from brain extracts since it cannot be solubilised in the 
first place. This may explain why we failed to detect a smaller form of 
teneurin-1 (e.g. the 55kDa form) by immunoprecipitation. In fact, many 
proteins are known to shuttle between different compartments e.g. 
(nuclear/cytoplasmic soluble or nuclear matrix associated/ insoluble form).  
Yet another speculative explanation for the 75kDa fragment is that this 
size of protein corresponds to a post-translationally modified intracellular form 
of IDten-1, which, in a similar manner as described above, shuttles between 
different compartments within the cell. Modifications such as ubiquitination or 
sumoylation will cause a protein to migrate slower in SDS-PAGE as compared 
to its unmodified form. Ubiquitination and sumoylation are known to target 
proteins to nuclear substructures and play a role in the regulation of gene 
expression (Gill, 2004). Thus, immunoprecipitated teneurin-1 could be 
analysed by immunoblotting with anti-ubiquitin and anti- sumo antibodies for 
the presence of these modifications.  
Intriguingly, on Western blots of nuclear matrices of chicken brain 
extracts and CEF cells, bands of 75kDa and 55kDa were detected with anti-N 
antibody that were absent with control pre-immune serum (cf. supplementary 
figure 2). This provides support for the possibility that the 75kDa band could 
be a modified nuclear form of the teneurin-1 intracellular domain. More 
experiments will be necessary to confirm the specificity of the signals detected 
in the Western blots. One approach could be RNA-interference in CEF cells to 
confirm the specificity of the bands observed. 
 
Strategy 2. Yeast two-hybrid screen to identify interacting proteins of the 
IDten-1 
In collaboration with Jacqueline Ferralli, who performed the yeast two-
hybrid screen, it was possible to identify two highly interesting proteins 
interacting with IDten-1; CAP/ponsin and MBD1. Hopefully they will 
contribute to a better understanding of teneurin-1 function. The experiments 
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describing the interacting proteins of teneurin-1; CAP/ponsin and MBD1 are 
discussed in detail in (Nunes et al., 2005). Since CAP/ponsin is found in a 
multi-protein complex at cell-cell and cell-ECM sites and teneurin-1 is present 
as a transmembrane protein, we envisaged a scenario where both proteins 
would co-function at these sites. Indeed, in overexpression experiments, both 
proteins showed a colocalisation at cell-cell interaction sites. Interestingly 
CAP/ponsin, which by itself showed specific cytoskeletal staining, upon co-
transfection with IDten-1 was translocated to the nucleus, the main site where 
IDten-1 accumulated. Previously, a nuclear function for CAP/ponsin has been 
reported. The protein was shown to interact with the mouse homologue of the 
human zinc-finger transcription factor INSM1 (IA-1) expressed during embryo 
development (Xie et al., 2002). IA-1 had a restricted distribution in the 
embryonic nervous system and tumours of neuroendocrine origins (Breslin et 
al., 2003). In addition, CAP/ponsin was found to be present in the nucleus of 
the mouse mammary tumour cell line MTD-1A but the significance of this 
nuclear staining was unclear (Mandai et al., 1999). All these findings provide 
additional indications that CAP/ponsin and IDten-1 may function in the 
nucleus.     
The other interacting protein of the IDten-1 found in the two-hybrid 
screen was the transcription repressor MBD1. This was the first direct link of 
IDten-1 to gene regulation since certain domains present in MBD1 are 
responsible for binding to DNA and for remodelling of chromatin (Fujita et al., 
2003). However, despite the identification of these interacting proteins and the 
knowledge of some of their functions, many questions remain. For instance, 
what is the relevance of these interactions and their functional consequence? 
When are they taking place in a cell and to which signalling pathway do they 
belong to? Ultimately, what is the contribution of these interactions to gene 
regulation? In the case of MBD1, it was shown that the protein could repress 
transcription specifically (Fujita et al., 1999). Therefore, it could be tested 
whether interaction with IDten-1 increases or relieves this repression.  
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Strategy 3. Microarray analysis 
Microarray experiments were performed using the EcR-IDten-1 cell 
line, where we can mimic the induction of the putative intracellular teneurin 
fragment that translocates to the nucleus. Expression patterns of genes 
responding to the absence or presence of IDten-1 were analysed. Interestingly, 
the expression of the XM_039676 gene was found to be dramatically induced 
after stimulation of IDten-1 protein expression and it was therefore chosen for 
further analyses. The protein encoded by this gene (KIAA1240) is predicted to 
harbour a bromodomain, which is often present in proteins possessing 
chromatin-remodelling properties. Proteins that contain this motif are 
implicated both in transcriptional activation and repression (Denis, 2001). 
However, the domain is also found in several proteins not directly participating 
in chromatin modification - the Drosophila fsh gene and the related RING3 
gene encode nuclear protein kinases (Denis et al., 2000), and several of the 
non-enzymatic components of the ATP-dependent remodelers (e.g. RSC1/2/3 
and Polybromo) also contain essential bromodomains (Cairns et al., 1999). 
Overall, bromodomain-containing proteins have been implicated in functions as 
diverse as cell-cycle control (CCG1 and RING3) (Denis et al., 2000), cellular 
differentiation (the Drosophila genes fsh and brm) (Tamkun, 1995), 
transcriptional regulation (SWI/SNF and RSC) and mitotic chromatin dynamics 
(Dey et al., 2000). Moreover, the relationship between acetyllysine and 
bromodomains is reminiscent of the specific recognition of phosphorylated 
residues by phospho-specific binding molecules such as SH2 domains and 14-
3-3 proteins. Bromodomains of Gcn5, PCAF, TAF1 and CBP are able to 
recognize acetyllysine residues in histones, HIV Tat, p53, c-Myb or MyoD 
(Yang, 2004). 
In addition to the bromodomain an AAA domain (ATPase Associated to 
a variety of cellular Activities) was found in the protein encoded by the 
XM_039676 gene. The key feature of this domain is a highly conserved 
module of 230 amino acids present as one or two copies per protein 
(Confalonieri and Duguet, 1995). Very recent reports implicate a highly 
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conserved AAA-ATPase in spindle disassembly at the end of mitosis 
(Cheeseman and Desai, 2004). The proteasome and related energy-dependent 
proteases, as well as NSF, p97, and Hsp104, all employ AAA+ ATPase 
domains for reactions that involve protein remodelling, unfolding, or 
disaggregation. ATPases can also function independently of peptidases as 
disassembly chaperones to dismantle protein complexes and to solubilise 
aggregates (Sauer et al., 2004). 
Interestingly, the Drosophila brahma (brm) gene contains both bromo 
and ATPase domains (Tamkun et al., 1992). The brahma complex of 
Drosophila is a SWI/SNF-related chromatin remodelling complex required to 
correctly maintain proper states of gene expression through ATP-dependent 
modification of chromatin structure (Marenda et al., 2004). Further studies will 
need to be performed to determine the function of our newly identified 
KIAA1240 protein harbouring these domains.   
To exclude the possibility that induction of XM_039676 by IDten-1 was 
an artefact of the particular clone used for the gene array, the activation of the 
XM_039676 gene was tested in other clones overexpressing IDten-1. We could 
confirm that this induction was reproducible in several other clones but not all 
clones induced expression of the transcript to the same extent. This could be 
interpreted as follows: (1) there are cell clone-dependent differences in the way 
this gene is regulated that are independent of IDten-1, (2) each clone behaves 
somewhat different depending on the insertion site of the transgene into the 
host genome and in some clones the transgene may even have been rearranged 
when it inserted into the host cell genome, thus expressing a potentially non-
functional IDten-1, (3) each clone displays different kinetics and possibly 
varied levels of expression of IDten-1 and (4) there is the possibility of a 
negative feedback loop to repress XM_039676 expression after it has been 
induced. If one assumes that IDten-1 must form stoichiometric complexes with 
co-factors to regulate gene expression it is conceivable that too high levels of 
IDten-1 protein eventually results in the formation of non-functional 
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complexes, mimicking a dominant negative effect. These hypotheses are highly 
speculative, but merit further investigations in the future. 
Clearly, the following points need to be addressed: (i) is the IDten-1 
involved directly in the activation of the XM_039676 gene and (ii) does it 
function as a co-factor in association with other proteins in a yet-to-be defined 
signalling complex?  
One possibility is that IDten-1/MBD1/Ponsin complexes are involved in 
regulating the methylation status of the XM_039676 promoter region. Thus, the 
gene could be induced by removal of inhibitory DNA-methylation. In this 
context, it could be checked if the promoter region of the XM_039676 is 
methylated or not. Furthermore, depletion of MBD1 and/or Ponsin (the former 
may be required to recognize methylated DNA regions) by siRNA could be 
useful to determine if they are required for the induction of the XM_039676 
gene in cell clones expressing IDten-1.    
If the promoter region of this newly identified gene induced by IDten-1 
is a direct target of IDten-1-containing DNA regulatory complexes, it will be 
possible to use the induction of XM_039676 expression as a read out of 
teneurin-1 signalling. For example, one could compare different stimuli and 
measure the levels of activation of the XM_039676 gene as a consequence of 
cleavage and translocation of IDten-1 to the nucleus. The promoter sequence 
could be cloned in front of a luciferase reporter to monitor its activation. This 
would allow pinpointing the IDten-1 dependent gene-regulatory region by 
introducing deletions. Using this approach, it could also be possible to identify 
regions containing modulators that might up- or downregulate the expression of 
the target gene.  
In a more indirect way, cell clones stably expressing full-length 
teneurin-1 could be transfected with various protease-encoding constructs and 
screened for induction of the XM_039676 gene (e.g. by RT-PCR) or of a 
cotransfected luciferase reporter construct in an attempt to identify the 
physiologically relevant candidate that promotes teneurin-1 cleavage. An 
alternative way to find teneurin-1 cleaving proteases would be the adaptation of 
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a widely used strategy in protease(s) screenings. Steiner et al. have reported an 
in vivo assay for the identification of target proteases, which cleave membrane-
associated substrates (Steiner et al., 1999). For instance, by measuring the 
activity of a reporter gene, one could test if the transmembrane sequence of 
teneurin-1, containing the cleavage sites for potential target proteases cloned in 
frame with GAL 4, would be able to induce the growth of a yeast strain 
harbouring a GAL1-His operon in the absence of histidine. 
Apart from the XM_039676 gene, some other interesting genes still 
remain to be analysed. Of interest are the ones present in the analysis that can 
be classified in a group with the XM_039676 gene based on their expression 
profile (table 4). In addition, candidate genes that could lead to reduced 
proliferation and genes potentially associated with increased differentiation 
were analysed. Some interesting candidates from the 1-Way ANOVA list are 
shown in the next table (table 5). However, such correlations may become 
more evident only when performing microarray analysis after longer IDten-1 
induction. 
 
Table 4: Group of genes with similar expression kinetics as compared to the 
XM_039676 gene 
C9orf7 (chromosome 9 open reading frame 7) 
KCND1 (potassium voltage-gated channel, Shal-related subfamily member 1) 
CLDN3 (claudin 3)  
MGC3038 (hypothetical protein similar to actin related protein 2/3 complex subunit 5) 
PBXIP1 (pre-B-cell leukemia transcription factor interacting protein 1) 
EGLN2 (egl nine homolog C. elegans) 
JPH2 (junctophilin 2) 
IGKC (immunoglobulin kappa constant) 
 
 
 
 
 
 
 
Samantha Michele Nunes Radimerski 115
Discussion 
 
Table 5: Genes that are potentially involved in cell proliferation and cell 
differentiation 
YWHAH (evidence of involvement in regulation of neuron differentiation) 
GADD45B (evidence of involvement in cell differentiation) 
IFITM1 (negative regulation of cell proliferation) 
RBM9 (regulation of cell proliferation) 
 
Finally, chromatin immunoprecipitation could be an appropriate 
extension of the DNA-microarray analysis. With the use of the antibodies 
generated to immunoprecipitate IDten-1 it would be possible to investigate 
whether IDten-1 and/or MBD1 are part of a protein complex binding to DNA 
that contains the XM_039676 gene detected by PCR. 
To finalize I would like to propose a possible model that would integrate 
some of the findings discussed above (figure 20). Teneurin-1, upon yet-to-be 
identified stimuli, is cleaved at the cell membrane and its intracellular domain 
translocates to the nucleus together with CAP/ponsin. In the nucleus, most 
likely as a response to specific signals, the IDten-1 shuttles to the insoluble 
nuclear matrix. In complexes that may involve MBD1/Ponsin or not, IDten-1 
appears to be involved in regulating XM_039676 gene expression. The 
KIAA1240 protein may itself be involved in chromatin remodelling and may 
trigger changes in histone acetylation by recruiting HDACs to those genes that 
are ultimately responsible for the observed reduction in the rate of cell 
proliferation of cells expressing IDten-1. Indeed, changes in chromatin 
topology e.g. induced by HDAC inhibitors can block cell proliferation, induce 
apoptosis or differentiation (Atadja et al., 2004; Nimmanapalli et al., 2003).  
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MEQMDCKPYQPLSKVKHEVDLTYTSSSDESEDGRKQRQSYDSRETLNEYSQELRLNYNSQSR
KRKNTDQSTQDMEFCETPHILCSGYQTDLHGVSEHSYPLEVGSDVDTETEGGASPDHALRMW
MRGMKSEHSSCLSSRANSALSLTDTDHERKSDGENDMPGSPHNQFTFRPLPPPPPPPHACTC
TRKPPPAADSLQRRSMTTRSQPSPAAPTPPTSTQDSVHLHNSWVLNSNIPLETRHFLFKHGS
GSSAIFSAASQNYPLTSNTVYSPPPRPLPRNTFSRPAFTFSKPYRCCNWKCTALSATAITVT
LALLLAYVIAVHLFGLTWQLQPVEGQLYENGVSKGNKGAESTDTTYSPIGGKVSDKTEKKVF
QKGRAIDTGEVEIGAQVMQTIPPGLFWRFQITIHHPVYLKFNISLAKDSLLGIYGRRNIPPT
HTQFDFVKLMDGKQLIKQEPKNSEEPQQAPRNLILTSLQETGFIEYMDQGAWHMAFYNDGKK
VEQVFVLTTAIEVLDDCSTNCNGNGECISGHCHCFPGFLGPDCAKDSCPVLCSGNGEYEKGH
CVCRNGWKGPECDVPEEQCIDPTCFGHGTCIMGVCICVPGYKGEICEEEDCLDPMCSGHGVC
VQGECHCSAGWGGVNCETSLPICQEHCSGHGTFLLDVGLCSCEPQWTGSDCSTELCTLDCGS
HGVCSRGICQCEEGWVGPTCEERTCHSHCAEHGQCKDGKCECSPGWEGDHCTIDGCPGLCYG
NGRCTLDQNGWHCVCQVGWSGSGCNVVMEMACGDNLDNDGDGLTDCVDPDCCQQNNCYASPL
CQGSPDPLDLIQHSQPPFSQHPPRLFYDRIRFLIGKESTHVIPGDISFESRRASVIRGQVVA
IDGTPLVGVNVSFLHHDEYGYTISRQDGSFDLVAVGGISVTLVFDRSPFISEKRTLWLSWNR
FVIVDKVVMQRAESDIPSCDVSSFISPNPIVLPSPLTAFGGSCPERGTVIPELQVVQEEIPI
PSSFVKLSYLSSRTPGYKTLLRVILTHTTIPSGMTKVHLIIAVEGRLLQKWFPAAANLVYTF
AWNKTDIYGQKVSGLAEAMVSVGYEYETCPDFILWEKRTVILQGFEMDASNLGGWSINKHHV
LNPQSGIVHKGNGENMFISQQPPVISTMMGNGHQRSVSCSNCNGLALNSKLFAPVALTSGPD
GSVYIGDFNFVRRIFPSGNSIGILELRNRDTRHSTSPAHKYYLAVDPVSESLYLSDTNTRRV
YKAKSLIETKDLAKNVDVVAGTGDQCLPFDQSHCGDGGKASEASLNSPRGITIDKHGFIYFV
DGTMIRKIDENGMITTIIGSNGLTSTQPLSCDSGMDITQVRLEWPTDLTVNPLDNSLYVLDN
NIVLQISESRRVRIIAGRPIHCQVPGIDHFIVSKVAIHSTLESARAIAVSHSGIPYIRETDE
RKINRIQQVTTNGEISIIAGAPSDCDCKIDPNCDCFSGDGGYAKDAKLKAPSSLAVSPDDTL
YVADLGNIRIRAVSRNKAHLSDTNMYEIASPADQELYQFTINGTHLHTLNLITRDYIYNFTY
SGEGDVATITSSNGNSVHIRRDTSGLPLWVVVPGGQVYWLTISSNGVLKRVYAQGYNLALMT
YPGNTGLLATKSDENGWTTVYEYDSDGHLTNATFPTGEVSSFHSDVEKLTRVELDTSNRENM
VTATNFSATSTIYTLKQDNTQNIYRVSPDGSLRVTFASGMEITLNTEPHILAGVVSPTLGKC
NISLPGEHNSNLIEWRQRREQTKGNISTFERRLRAHNRNLLSIDFDHVTRTGKIYDDHRKFT
LRIMYDQTGRPVLWSPISKYNEVNITYSHSGLVTYIQRGTWTEKMEYDPSGNIISRTWADGK
IWSYTYLEKSVMLLLHSQRRYIFEYDQSDYLLSVTMPSMVRHALQTMLSVGYYRNIYTPPDS
GAAFIQDVTRDGRLLQTLYPGTGRRVLYKYSKQSRLSEILYDTTQVTFTYEESSGVIKTIHL
MHDGFICTIRYRQTGPLIGRQIFRFSEEGLVNARFDYSYNNFRVTSMQAMINETPLPIDLYR
YVDVSGRTEQFGKFSVINYDLNQVITTTVMKHTKIFSANGQVIEVQYEILKSIAYWMTIQYD
NMGRMVICDIRVGVDANITRYFYEYDRDGQLQTVSVNDKTQWRYSYDLNGNINLLSHGNSAR
LTPLRYDLRDRITRLGEIQYKMDEDGFLRQRGNEIFEYNSNGLLNKAYNKVSGWTVQYCYDG
LGRRVASKSSLGQHLQFFYADLSNPIRVTHLYNHSSSEITSLYYDLQGHLIAMELSSGEEYY
VACDNTGTPLAVFSSRGQVIKEILYTPYGEIYQDTNPDFQVVIGFHGGLYDSLTKLVHLGQR
DYDVIAGRWTTPNHHIWKHLNAVPQPFNLYSFENNYPVGRIQDVAKYTTDIGSWLELFGFQL
HNVLPGFPKPEIEALETTYELLQLQTKTQEWDPGKTILGIQCELQKQLRNFISLDQLPMTPR
YSDGKCYEGVKQPRFAAIPSVFGKGIKFAIKDGIVTADIIGVANEDSRRIAAILNNAHYLEN
LHFTIEGRDTHYFIKLGSLEEDLSLIGNTGGRRILENGVNVTVSQMTSVINGRTRRFADIQL
QHGALCFNVRYGTTVEEEKNHVLEVARQRAVAQAWTKEQRRLQEGEEGIRAWTDGEKQQLLN
TGRVQGYDGYFVLSVEQYLELSDSANNIHFMRQSEIGRR 
 
Figure 19. Amino acid sequence of teneurin-1 protein. Putative S1P cleavage sites 
present in the protein are highlighted in blue. The particular S1P cleavage site of 
interest that could generate a fragment of approximately 80kDa is depicted in red. The 
teneurin-1 transmembrane domain is highlighted in yellow. Dibasic arginine and 
lysine residues in the vicinity of the transmembrane domain that have the potential to 
serve as recognition sites for proteases are shown underlined. 
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Figure 20. Proposed model for teneurin-1 signalling. Teneurin-1, upon cleavage at 
the cell membrane by unknown proteases, releases its intracellular domain. The 
IDten-1 then translocates to the nucleus together with CAP/ponsin where, in 
association with MBD1, it may be involved in the regulation of target genes like for 
example the XM_039676 gene, which was identified in the microarray analysis. 
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VI. APPENDIX 
List I - 1 Way ANOVA 
Affy Annotation Description Abbreviation 
221168_at PR domain containing 13 PRDM13 
213135_at T-cell lymphoma invasion and metastasis 1 TIAM1 
210276_s_at Tara-like protein HRIHFB2122 
208663_s_at tetratricopeptide repeat domain 3 TTC3 
213721_at SRY (sex determining region Y)-box 2 SOX2 
220209_at peptide YY, 2 (seminalplasmin) PYY2 
213641_at KIAA0557 protein KIAA0557 
201739_at serum/glucocorticoid regulated kinase SGK 
201300_s_at 
prion protein (p27-30) (Creutzfeld-Jakob disease, 
Gerstmann-Strausler-Scheinker syndrome, fatal 
familial insomnia) PRNP 
214464_at CDC42 binding protein kinase alpha (DMPK-like) CDC42BPA 
202477_s_at tubulin, gamma complex associated protein 2 TUBGCP2 
217403_s_at zinc finger protein 227 ZNF227 
204720_s_at DnaJ (Hsp40) homolog, subfamily C, member 6 DNAJC6 
218294_s_at nucleoporin 50kDa NUP50 
217775_s_at retinol dehydrogenase 11 (all-trans and 9-cis) RDH11 
211952_at karyopherin (importin) beta 3 KPNB3 
210793_s_at nucleoporin 98kDa NUP98 
204004_at PRKC, apoptosis, WT1, regulator PAWR 
201708_s_at nipsnap homolog 1 (C. elegans) NIPSNAP1 
200676_s_at ubiquitin-conjugating enzyme E2L 3 UBE2L3 
207753_at zinc finger protein 304 ZNF304 
201611_s_at isoprenylcysteine carboxyl methyltransferase ICMT 
217986_s_at bromodomain adjacent to zinc finger domain, 1A BAZ1A 
204047_s_at chromosome 6 open reading frame 56 C6orf56 
207081_s_at 
phosphatidylinositol 4-kinase, catalytic, alpha 
polypeptide PIK4CA 
221646_s_at zinc finger, DHHC domain containing 11 ZDHHC11 
218726_at hypothetical protein DKFZp762E1312 DKFZp762E1312
208802_at signal recognition particle 72kDa SRP72 
208228_s_at 
fibroblast growth factor receptor 2 (bacteria-expressed kinase, 
keratinocyte growth factor receptor, craniofacial dysostosis 1, 
Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) FGFR2 
218092_s_at HIV-1 Rev binding protein HRB 
213376_at zinc finger and BTB domain containing 1 ZBTB1 
204799_at zinc finger, BED domain containing 4 ZBED4 
208934_s_at lectin, galactoside-binding, soluble, 8 (galectin 8) LGALS8 
212361_s_at 
ATPase, Ca++ transporting, cardiac muscle, slow 
twitch 2 ATP2A2 
203570_at lysyl oxidase-like 1 LOXL1 
220707_s_at hypothetical protein FLJ23322 FLJ23322 
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207574_s_at growth arrest and DNA-damage-inducible, beta GADD45B 
207826_s_at 
inhibitor of DNA binding 3, dominant negative 
helix-loop-helix protein ID3 
217975_at pp21 homolog LOC51186 
213598_at putative dimethyladenosine transferase HSA9761 
212693_at Homo sapiens transcribed sequences --- 
202703_at 
dual specificity phosphatase 11 (RNA/RNP 
complex 1-interacting) DUSP11 
202943_s_at N-acetylgalactosaminidase, alpha- NAGA 
212248_at LYRIC/3D3 LYRIC 
212206_s_at histone H2A.F/Z variant H2AV 
210735_s_at carbonic anhydrase XII CA12 
201819_at scavenger receptor class B, member 1 SCARB1 
221987_s_at hypothetical protein FLJ10534 FLJ10534 
203058_s_at 3'-phosphoadenosine 5'-phosphosulfate synthase 2 PAPSS2 
208933_s_at hypothetical protein FLJ10359 FLJ10359 
212113_at 
Homo sapiens mRNA; cDNA DKFZp313P052 
(from clone DKFZp313P052) --- 
216215_s_at RNA binding motif protein 9 RBM9 
206061_s_at Dicer1, Dcr-1 homolog (Drosophila) DICER1 
213035_at KIAA0379 protein KIAA0379 
218358_at hypothetical protein MGC11256 MGC11256 
218626_at 
eukaryotic translation initiation factor 4E nuclear 
import factor 1 EIF4ENIF1 
201900_s_at 
aldo-keto reductase family 1, member A1 
(aldehyde reductase) AKR1A1 
205501_at 
Homo sapiens cDNA FLJ25677 fis, clone 
TST04054 --- 
201150_s_at 
tissue inhibitor of metalloproteinase 3 (Sorsby 
fundus dystrophy, pseudoinflammatory) TIMP3 
207781_s_at zinc finger protein 6 (CMPX1) ZNF6 
221516_s_at hypothetical protein FLJ20232 FLJ20232 
212271_at mitogen-activated protein kinase 1 MAPK1 
204637_at glycoprotein hormones, alpha polypeptide CGA 
214659_x_at ZAP3 protein ZAP3 
210416_s_at CHK2 checkpoint homolog (S. pombe) CHEK2 
212157_at 
syndecan 2 (heparan sulfate proteoglycan 1, cell 
surface-associated, fibroglycan) SDC2 
207060_at engrailed homolog 2 EN2 
213682_at nucleoporin 50kDa NUP50 
219437_s_at nasopharyngeal carcinoma susceptibility protein LZ16 
203031_s_at 
uroporphyrinogen III synthase (congenital 
erythropoietic porphyria) UROS 
203089_s_at protease, serine, 25 PRSS25 
206245_s_at influenza virus NS1A binding protein IVNS1ABP 
202944_at N-acetylgalactosaminidase, alpha- NAGA 
201569_s_at CGI-51 protein CGI-51 
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205980_s_at Rho GTPase activating protein 8 ARHGAP8 
64474_g_at hypothetical protein FLJ22127 FLJ22127 
219180_s_at peroxisome biogenesis factor 26 PEX26 
202478_at tribbles homolog 2 TRB2 
217445_s_at 
phosphoribosylglycinamide formyltransferase, 
phosphoribosylglycinamide synthetase, 
phosphoribosylaminoimidazole synthetase GART 
200749_at RAN, member RAS oncogene family RAN 
204593_s_at hypothetical protein FLJ20232 FLJ20232 
208712_at cyclin D1 (PRAD1: parathyroid adenomatosis 1) CCND1 
203639_s_at 
fibroblast growth factor receptor 2 (bacteria expressed kinase, 
keratinocyte growth factor receptor, craniofacial dysostosis 1, 
Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) FGFR2 
201020_at 
tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase 
activation protein, eta polypeptide YWHAH 
202225_at 
Homo sapiens cDNA FLJ38130 fis, clone 
D6OST2000464. --- 
202211_at 
ADP-ribosylation factor GTPase activating protein 
3 ARFGAP3 
212596_s_at high-mobility group protein 2-like 1 HMG2L1 
203401_at phosphoribosyl pyrophosphate synthetase 2 PRPS2 
202990_at 
phosphorylase, glycogen; liver (Hers disease, 
glycogen  storage disease type VI) PYGL 
208890_s_at plexin B2 PLXNB2 
207830_s_at protein phosphatase 1, regulatory (inhibitor) subunit 8 PPP1R8 
213626_at hypothetical protein FLJ14431 FLJ14431 
205206_at Kallmann syndrome 1 sequence KAL1 
201641_at bone marrow stromal cell antigen 2 BST2 
211725_s_at BH3 interacting domain death agonist BID 
209994_s_at 
ATP-binding cassette, sub-family B (MDR/TAP), 
member 1 ABCB1 
220940_at KIAA1641 protein KIAA1641 
213577_at squalene epoxidase SQLE 
216251_s_at KIAA0153 protein KIAA0153 
201601_x_at interferon induced transmembrane protein 1 (9-27) IFITM1 
208002_s_at brain acyl-CoA hydrolase BACH 
55081_at molecule interacting with Rab13 MIRAB13 
205335_s_at signal recognition particle 19kDa SRP19 
209598_at paraneoplastic antigen MA2 PNMA2 
205350_at cellular retinoic acid binding protein 1 CRABP1 
201928_at plakophilin 4 PKP4 
201929_s_at plakophilin 4 PKP4 
203164_at 
solute carrier family 33 (acetyl-CoA transporter), 
member 1 SLC33A1 
206874_s_at Ste20-related serine/threonine kinase SLK 
213880_at G protein-coupled receptor 49 GPR49 
208817_at catechol-O-methyltransferase COMT 
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202816_s_at synovial sarcoma translocation, chromosome 18 SS18 
218421_at ceramide kinase CERK 
217870_s_at UMP-CMP kinase UMP-CMPK 
217738_at pre-B-cell colony-enhancing factor PBEF 
206106_at mitogen-activated protein kinase 12 MAPK12 
206833_s_at acylphosphatase 2, muscle type ACYP2 
212993_at hypothetical protein MGC23427 MGC23427 
210732_s_at lectin, galactoside-binding, soluble, 8 (galectin 8) LGALS8 
201650_at keratin 19 KRT19 
208833_s_at like mouse brain protein E46 E46L 
209305_s_at growth arrest and DNA-damage-inducible, beta GADD45B 
211754_s_at 
solute carrier family 25 (mitochondrial carrier; 
peroxisomal 
membrane protein, 34kDa), member 17 SLC25A17 
204620_s_at chondroitin sulfate proteoglycan 2 (versican) CSPG2 
214794_at proliferation-associated 2G4, 38kDa PA2G4 
209407_s_at 
deformed epidermal autoregulatory factor 1 
(Drosophila) DEAF1 
203196_at 
ATP-binding cassette, sub-family C (CFTR/MRP), 
member 4 ABCC4 
214022_s_at interferon induced transmembrane protein 1 (9-27) IFITM1 
201627_s_at insulin induced gene 1 INSIG1 
210010_s_at 
solute carrier family 25 (mitochondrial carrier; citrate 
transporter), member 1 SLC25A1 
200683_s_at ubiquitin-conjugating enzyme E2L 3 UBE2L3 
200732_s_at protein tyrosine phosphatase type IVA, member 1 PTP4A1 
205881_at zinc finger protein 74 (Cos52) ZNF74 
208351_s_at mitogen-activated protein kinase 1 MAPK1 
37117_at Rho GTPase activating protein 8 ARHGAP8 
219959_at molybdenum cofactor sulfurase HMCS 
204594_s_at hypothetical protein FLJ20232 FLJ20232 
205037_at RAB, member of RAS oncogene family-like 4 RABL4 
208284_x_at gamma-glutamyltransferase 1 GGT1 
200684_s_at ubiquitin-conjugating enzyme E2L 3 UBE2L3 
209656_s_at transmembrane 4 superfamily member 10 TM4SF10 
205822_s_at 
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 
1 (soluble) HMGCS1 
200597_at 
eukaryotic translation initiation factor 3, subunit 10 
theta, 150/170kDa EIF3S10 
204126_s_at CDC45 cell division cycle 45-like (S. cerevisiae) CDC45L 
204693_at CDC42 effector protein (Rho GTPase binding) 1 CDC42EP1 
209590_at bone morphogenetic protein 7 (osteogenic protein 1) BMP7 
212190_at 
serine (or cysteine) proteinase inhibitor, clade E (nexin, 
plasminogen activator inhibitor type 1), member 2 SERPINE2 
214752_x_at filamin A, alpha (actin binding protein 280) FLNA 
208174_x_at U2(RNU2) small nuclear RNA auxiliary factor 1-like 2 U2AF1L2 
209200_at 
MADS box transcription enhancer factor 2, 
polypeptide C (myocyte enhancer factor 2C) MEF2C 
Samantha Michele Nunes Radimerski 137
Appendix 
201362_at influenza virus NS1A binding protein IVNS1ABP 
208711_s_at cyclin D1 (PRAD1: parathyroid adenomatosis 1) CCND1 
219629_at hypothetical protein FLJ20635 FLJ20635 
213405_at Homo sapiens transcribed sequences --- 
206002_at G protein-coupled receptor 64 GPR64 
206356_s_at 
guanine nucleotide binding protein (G protein), alpha 
activating activity polypeptide, olfactory type GNAL 
201570_at CGI-51 protein CGI-51 
215977_x_at glycerol kinase GK 
208667_s_at 
suppression of tumorigenicity 13 (colon carcinoma) 
(Hsp70 interacting protein) ST13 
204684_at neuronal pentraxin I NPTX1 
215867_x_at 
adaptor-related protein complex 1, gamma 1 
subunit AP1G1 
209504_s_at 
pleckstrin homology domain containing, family B 
(evectins) member 1 PLEKHB1 
221787_at PHD finger protein 10 PHF10 
209218_at squalene epoxidase SQLE 
215460_x_at bromodomain containing 1 BRD1 
214639_s_at homeo box A1 HOXA1 
203450_at chromosome 22 open reading frame 2 C22orf2 
200632_s_at N-myc downstream regulated gene 1 NDRG1 
212124_at retinoic acid induced 17 RAI17 
210027_s_at 
APEX nuclease (multifunctional DNA repair 
enzyme) 1 APEX1 
200859_x_at filamin A, alpha (actin binding protein 280) FLNA 
212480_at KIAA0376 protein KIAA0376 
44783_s_at hairy/enhancer-of-split related with YRPW motif 1 HEY1 
209761_s_at SP110 nuclear body protein SP110 
206103_at 
ras-related C3 botulinum toxin substrate 3 (rho 
family, small GTP binding protein Rac3) RAC3 
209220_at glypican 3 GPC3 
205555_s_at msh homeo box homolog 2 (Drosophila) MSX2 
203963_at carbonic anhydrase XII CA12 
201651_s_at 
protein kinase C and casein kinase substrate in 
neurons 2 PACSIN2 
211571_s_at chondroitin sulfate proteoglycan 2 (versican) CSPG2 
203638_s_at 
fibroblast growth factor receptor 2 (bacteria-expressed kinase, 
keratinocyte growth factor receptor, craniofacialdysostosis 1, 
Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) FGFR2 
206853_s_at mitogen-activated protein kinase kinase kinase 7 MAP3K7 
208504_x_at protocadherin beta 11 PCDHB11 
204678_s_at potassium channel, subfamily K, member 1 KCNK1 
208666_s_at 
suppression of tumorigenicity 13 (colon carcinoma) 
(Hsp70 interacting protein) ST13 
201965_s_at KIAA0625 protein KIAA0625 
218592_s_at cat eye syndrome chromosome region, candidate 5 CECR5 
209210_s_at pleckstrin homology domain containing, family C PLEKHC1 
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(with FERM domain) member 1 
212352_s_at transmembrane trafficking protein TMP21 
33323_r_at stratifin SFN 
215603_x_at 
Homo sapiens similar to Gamma-glutamyltranspeptidase 1 
precursor (Gamma-glutamyltransferase 1) (CD224 antigen) 
(LOC348598), mRNA --- 
221805_at neurofilament, light polypeptide 68kDa NEFL 
201142_at 
eukaryotic translation initiation factor 2, subunit 1 
alpha, 35kDa EIF2S1 
212646_at raft-linking protein RAFTLIN 
203438_at stanniocalcin 2 STC2 
201147_s_at 
tissue inhibitor of metalloproteinase 3 (Sorsby fundus 
dystrophy, pseudoinflammatory) TIMP3 
202144_s_at adenylosuccinate lyase ADSL 
209919_x_at gamma-glutamyltransferase 1 GGT1 
218423_x_at vacuolar protein sorting 54 (yeast) VPS54 
210319_x_at msh homeo box homolog 2 (Drosophila) MSX2 
208818_s_at catechol-O-methyltransferase COMT 
212528_at Homo sapiens, clone IMAGE:3605655, mRNA --- 
206291_at neurotensin NTS 
205241_at 
SCO cytochrome oxidase deficient homolog 2 
(yeast) SCO2 
207001_x_at delta sleep inducing peptide, immunoreactor DSIPI 
208370_s_at Down syndrome critical region gene 1 DSCR1 
212597_s_at high-mobility group protein 2-like 1 HMG2L1 
212167_s_at 
SWI/SNF related, matrix associated, actin 
dependent 
regulator of chromatin, subfamily b, member 1 SMARCB1 
213746_s_at filamin A, alpha (actin binding protein 280) FLNA 
207387_s_at glycerol kinase GK 
210250_x_at adenylosuccinate lyase ADSL 
215646_s_at chondroitin sulfate proteoglycan 2 (versican) CSPG2 
213604_at 
transcription elongation factor B (SIII), polypeptide 3 
(110kDa, elongin A) TCEB3 
203085_s_at 
transforming growth factor, beta 1 (Camurati-
Engelmann disease) TGFB1 
201363_s_at influenza virus NS1A binding protein IVNS1ABP 
207131_x_at gamma-glutamyltransferase 1 GGT1 
203417_at microfibrillar-associated protein 2 MFAP2 
217960_s_at 
translocase of outer mitochondrial membrane 22 
homolog (yeast) TOMM22 
206355_at 
guanine nucleotide binding protein (G protein), 
alpha 
activating activity polypeptide, olfactory type GNAL 
201755_at 
MCM5 minichromosome maintenance deficient 5, 
cell division cycle 46 (S. cerevisiae) MCM5 
218543_s_at hypothetical protein FLJ22693 FLJ22693 
213508_at chromosome 14 open reading frame 147 C14orf147 
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201995_at exostoses (multiple) 1 EXT1 
222240_s_at myo-inositol 1-phosphate synthase A1 ISYNA1 
217719_at 
eukaryotic translation initiation factor 3, subunit 6 
interacting protein EIF3S6IP 
214265_at integrin, alpha 8 ITGA8 
216237_s_at 
MCM5 minichromosome maintenance deficient 5, 
cell division cycle 46 (S. cerevisiae) MCM5 
208949_s_at lectin, galactoside-binding, soluble, 3 (galectin 3) LGALS3 
201076_at 
NHP2 non-histone chromosome protein 2-like 1 (S. 
cerevisiae) NHP2L1 
221731_x_at chondroitin sulfate proteoglycan 2 (versican) CSPG2 
208763_s_at delta sleep inducing peptide, immunoreactor DSIPI 
202391_at brain abundant, membrane attached signal protein 1 BASP1 
205110_s_at fibroblast growth factor 13 FGF13 
200005_at 
eukaryotic translation initiation factor 3, subunit 7 
zeta, 66/67kDa EIF3S7 
221410_x_at protocadherin beta 3 PCDHB3 
218839_at hairy/enhancer-of-split related with YRPW motif 1 HEY1 
211919_s_at chemokine (C-X-C motif) receptor 4 CXCR4 
205289_at bone morphogenetic protein 2 BMP2 
212527_at 
DNA segment, Chr 15, Wayne State University 75, 
expressed D15Wsu75e 
211417_x_at gamma-glutamyltransferase 1 GGT1 
211998_at H3 histone, family 3B (H3.3B) H3F3B 
213492_at 
collagen, type II, alpha 1 (primary osteoarthritis, 
spondyloepiphyseal dysplasia, congenital) COL2A1 
204735_at 
phosphodiesterase 4A, cAMP-specific 
(phosphodiesterase E2 dunce homolog, Drosophila) PDE4A 
205290_s_at bone morphogenetic protein 2 BMP2 
212741_at monoamine oxidase A MAOA 
206376_at homolog of rat orphan transporter v7-3 NTT73 
204359_at fibronectin leucine rich transmembrane protein 2 FLRT2 
209457_at dual specificity phosphatase 5 DUSP5 
208937_s_at 
inhibitor of DNA binding 1, dominant negative 
helix-loop-helix protein ID1 
202431_s_at 
v-myc myelocytomatosis viral oncogene homolog 
(avian) MYC 
200792_at thyroid autoantigen 70kDa (Ku antigen) G22P1 
200670_at X-box binding protein 1 XBP1 
209278_s_at tissue factor pathway inhibitor 2 TFPI2 
218251_at hypothetical protein STRAIT11499 STRAIT11499
213387_at KIAA1240 protein KIAA1240 
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List II - 2 Way ANOVA 
 
Affy Annotation Description Abreviation 
212124_at retinoic acid induced 17 RAI17 
221787_at PHD finger protein 10 PHF10 
209278_s_at tissue factor pathway inhibitor 2 TFPI2 
208370_s_at Down syndrome critical region gene 1 DSCR1 
204693_at CDC42 effector protein (Rho GTPase binding) 1 CDC42EP1 
209656_s_at transmembrane 4 superfamily member 10 TM4SF10 
206356_s_at 
guanine nucleotide binding protein (G protein), 
alpha activating activity polypeptide, olfactory type GNAL 
201965_s_at KIAA0625 protein KIAA0625 
203438_at stanniocalcin 2 STC2 
200684_s_at ubiquitin-conjugating enzyme E2L 3 UBE2L3 
215867_x_at adaptor-related protein complex 1, gamma 1 subunit AP1G1 
208711_s_at cyclin D1 (PRAD1: parathyroid adenomatosis 1) CCND1 
206853_s_at mitogen-activated protein kinase kinase kinase 7 MAP3K7 
201147_s_at 
tissue inhibitor of metalloproteinase 3 (Sorsby fundus 
dystrophy, pseudoinflammatory) TIMP3 
218423_x_at vacuolar protein sorting 54 (yeast) VPS54 
218543_s_at hypothetical protein FLJ22693 FLJ22693 
214639_s_at homeo box A1 HOXA1 
201142_at 
eukaryotic translation initiation factor 2, subunit 1 
alpha, 35kDa EIF2S1 
206355_at 
guanine nucleotide binding protein (G protein), alpha 
activating activity polypeptide, olfactory type GNAL 
221805_at neurofilament, light polypeptide 68kDa NEFL 
213604_at 
transcription elongation factor B (SIII), polypeptide 3 
(110kDa, elongin A) TCEB3 
207001_x_at delta sleep inducing peptide, immunoreactor DSIPI 
205241_at SCO cytochrome oxidase deficient homolog 2 (yeast) SCO2 
202431_s_at 
v-myc myelocytomatosis viral oncogene homolog 
(avian) MYC 
213746_s_at filamin A, alpha (actin binding protein 280) FLNA 
203085_s_at 
transforming growth factor, beta 1 (Camurati-
Engelmann disease) TGFB1 
206376_at homolog of rat orphan transporter v7-3 NTT73 
208763_s_at delta sleep inducing peptide, immunoreactor DSIPI 
201995_at exostoses (multiple) 1 EXT1 
211998_at H3 histone, family 3B (H3.3B) H3F3B 
200670_at X-box binding protein 1 XBP1 
205289_at bone morphogenetic protein 2 BMP2 
211919_s_at chemokine (C-X-C motif) receptor 4 CXCR4 
212527_at DNA segment, Chr 15, Wayne State University 75, expressed D15Wsu75e 
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205290_s_at bone morphogenetic protein 2 BMP2 
209457_at dual specificity phosphatase 5 DUSP5 
208937_s_at 
inhibitor of DNA binding 1, dominant negative helix-
loop-helix protein ID1 
218251_at hypothetical protein STRAIT11499 STRAIT11499 
213387_at KIAA1240 protein KIAA1240 
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June 1999 - June 2000: International Association for the Exchange of 
Students for Technical Experience (IAESTE) traineeship; studies on the 
MEA protein (FMI, Basel, supervisor: Prof. U. Grossniklaus). 
   
July 1998 - October 1998: Diploma work; studies on the PKC isoforms and 
the APC (Adenomatous polyposis coli) gene product in colon cancers. 
(Deutsches Institut für Ernährungsforschung, Potsdam, supervisor: Dr. K. 
Schmehl). 
 
August 1996 - July 1997: Fellowship; analysis of nephrotoxic effects of 
combined administration of cisplatin and sodium selenite in rats. (Department 
of Bromatology and Nutrition - USP, supervisor: Dr. ML Bianchi).   
 
January 1996 - July 1996: Traineeship; physical-chemical stability analysis of 
oil/water (O/W) emulsions (Cosmetic Technology Laboratory - USP, 
supervisor: Dr. PA Rocha Filho). 
 
January 1994 – December 1998: Undergraduate studies at the University of 
São Paulo (USP) - Pharmaceutical Sciences College of Ribeirão Preto. 
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 EXTRACURRICULAR ACTIVITIES AND COURSES 
2005: Intensive German language course, NSH Bildungszentrum, Basel. 
 
2003: Strategies and trends in pharmaceutical development and production 
course with project work, Pharmazentrum, Basel. 
 
2003: WIN (Women Into Industry) Mentoring Program, University of Basel 
and Novartis, Basel. 
 
1997: Courses at the Faculty of Economy and Management, University of 
São Paulo (USP), Ribeirão Preto: 
Human Resources Management  
Marketing Control and Planning  
Basic Marketing  
Organization Behaviour  
 
PERSONAL SKILLS 
Mother language:  Portuguese 
Other languages: English (strong command)  
German (good) 
Spanish (basic) 
 
PUBLICATIONS 
Nunes SM, Ferralli J, Choi K, Brown-Luedi M, Minet AD and Chiquet-
Ehrismann R. 2005. The intracellular domain of teneurin-1 interacts with 
MBD1 and CAP/ponsin resulting in subcellular codistribution and 
translocation to the nuclear matrix. Experimental Cell Research 305: 122-
132.  
 
Spillane C, MacDougall C, Stock C, Kohler C, Vielle-Calzada JP, Nunes SM, 
Grossniklaus U, Goodrich J. 2000. Interaction of the Arabidopsis polycomb 
group proteins FIE and MEA mediates their common phenotypes. Current 
Biology 10: 1535-8. 
 
Ferrari M, Maruno M, Goncalves, Nunes S, Rocha Filho PA. 1997. Allantoin 
Liberation from Liquid Dispersed Systems (O/W Emulsions and O/W/O 
Multiple Emulsions). Bollettino Chimico Farmaceutico 136: 119. 
   
UNIVERSITY LECTURES ATTENDED 
2000- Molecular Medicine (part I); Molecular Mechanisms of Development; 
Extracellular Matrix from Bone to Brain 
2001- Molecular Medicine (part II) 
2003- New Literature in Extracellular Matrix; Molecular Aspects of 
Neurologic Diseases 
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